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Abstract	  	   In	  human	  infection,	  herpes	  simplex	  virus	  (HSV)	  navigates	  two	  distinct	  life	  cycles;	  lytic	  and	  latent.	  The	  latent	  cycle	  takes	  place	  in	  sensory	  neurons,	  and	  is	  characterized	  as	  a	  dormant	  period	  punctuated	  by	  stress-­‐induced	  episodes	  of	  viral	  reactivation.	  Understanding	  the	  mechanisms	  by	  which	  HSV	  latency	  and	  reactivation	  occur	  has	  been	  hindered	  by	  the	  lack	  of	  a	  model	  that	  faithfully	  recapitulates	  the	  environment	  of	  a	  human	  sensory	  neuron.	  Systems	  ranging	  from	  rat	  neurons	  to	  human	  fibroblasts	  have	  been	  developed	  to	  host	  HSV	  latency,	  however	  few	  available	  models	  have	  been	  able	  to	  investigate	  the	  role	  of	  human	  neuron-­‐specific	  factors.	  To	  address	  this	  need,	  human	  medulloblastoma	  tumour	  cell	  lines,	  which	  derive	  from	  neuronal	  precursor	  cells,	  were	  differentiated	  and	  examined	  for	  their	  ability	  to	  host	  the	  HSV	  latency-­‐reactivation	  cycle—in	  a	  manner	  similar	  to	  the	  differentiated	  PC-­‐12	  cell	  model.	  ONS-­‐76	  and	  UW228	  medulloblastoma	  cell	  lines	  were	  screened	  for	  differentiation	  capacity.	  The	  differentiated	  cells	  were	  demonstrated	  to	  possess	  neuronal	  character	  as	  several	  neuron-­‐specific	  proteins	  were	  found	  to	  be	  expressed.	  Differentiated	  ONS-­‐76	  cells	  were	  not	  compatible	  with	  hosting	  HSV	  latency,	  however,	  infection	  with	  a	  viral	  mutant	  impaired	  for	  lytic	  cycle	  initiation	  exhibited	  a	  deviant	  pattern	  of	  gene	  expression	  that	  resembles	  what	  has	  been	  observed	  in	  reactivation.	  Differentiated	  UW228	  cells	  were	  found	  to	  host	  a	  low	  frequency,	  stable	  infection	  with	  the	  HSV	  mutant,	  characterized	  by	  the	  absence	  of	  infectious	  virus	  and	  viral	  lytic	  gene	  expression	  in	  the	  presence	  of	  persisting	  viral	  DNA.	  This	  DNA	  could	  further	  be	  induced	  to	  re-­‐enter	  the	  lytic	  cycle	  through	  heat	  shock	  treatment	  and	  removal	  of	  differentiating	  agents	  from	  cell	  cultures.	  These	  results	  depict	  differentiated	  medulloblastoma	  cells	  as	  a	  novel	  tool	  in	  the	  study	  of	  HSV	  latency	  and	  reactivation,	  as	  these	  cells	  derive	  from	  the	  central	  nervous	  system	  and	  provide	  a	  new	  cellular	  perspective	  through	  which	  HSV	  biology	  can	  be	  viewed.	  	  Keywords:	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   ethylenediaminetetraacetic	  acid	  FBS	   	   	   fetal	  bovine	  serum	  GAPDH	   	   glyceraldehyde-­‐3-­‐phosphate	  dehydrogenase	  GFAP	   	   	   glial	  fibrillary	  acidic	  protein	  GMP	   	   	   glassware	  and	  media	  preparation	  HCF	   	   	   host	  cell	  factor	  1	  HDAC	   	   	   histone	  deacetylase	  HMBA	  	   	   hexamethylene	  bis(acetamide)	  hpi	   	   	   hours	  post	  infection	  HSV	   	   	   herpes	  simplex	  virus	  type	  1	  HVEM	  	   	   herpesvirus	  entry	  mediator	  ICP0	   	   	   infected	  cell	  protein	  0	  ICP4	   	   	   infected	  cell	  protein	  4	  ICP27	   	   	   infected	  cell	  protein	  27	  IE	   	   	   immediate-­‐early	  
	   ix	  
IF	   	   	   indirect	  immunofluorescent	  staining	  iPS	   	   	   induced	  pluripotent	  stem	  cells	  kb	   	   	   kilobase	  pair	  LAT	   	   	   latency	  associated	  transcript	  MOI	   	   	   multiplicity	  of	  infection	  NBCS	   	   	   newborn	  calf	  serum	  ND10	   	   	   nuclear	  domain	  10	  NeuN	   	   	   neuronal	  nuclear	  antigen	  (Fox-­‐3)	  NF	   	   	   neurofilament	  NGF	   	   	   nerve	  growth	  factor	  Oct-­‐1	   	   	   POU	  domain	  octamer	  transcription	  factor	  1	  (POU2F1)	  PBS	   	   	   phosphate	  buffered	  saline	  PBST	   	   	   phosphate	  buffered	  saline	  +	  0.1%	  Triton-­‐X	  100	  Pen-­‐strep	   	   penicillin	  streptomycin	  pfu	   	   	   plaque	  forming	  units	  PI	   	   	   propidium	  iodide	  qRT-­‐PCR	   	   quantitative	  real-­‐time	  polymerase	  chain	  reaction	  RNA	   	   	   ribonucleic	  acid	  SDS	   	   	   sodium	  dodecyl	  sulfate	  TBE	   	   	   tris	  borate	  EDTA	  buffer	  TG	   	   	   trigeminal	  ganglia	  TK	   	   	   thymidine	  kinase	  TrkA	   	   	   neurotrophic	  tyrosine	  kinase	  receptor	  type	  1	  TSA	   	   	   trichostatin	  A	  UV	   	   	   ultraviolet	   	  VIC	   	   	   VP16-­‐induced	  complex	  VP5	   	   	   virion	  protein	  5	  VP16	  	   	   	   virion	  protein	  16	  ZF	  	   	   	   cyclic	  AMP	  responsive	  element	  binding	  protein	  (Zhangfei)
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Chapter	  1 Introduction	  	   Herpes	  simplex	  virus	  type	  1	  (HSV)	  is	  a	  human	  pathogen	  that	  navigates	  two	  distinct	  replicative	  programs	  within	  its	  host;	  lytic	  and	  latent.	  In	  lytic	  replication	  the	  virus	  rapidly	  produces	  progeny	  via	  a	  regulated	  program	  of	  gene	  expression.	  By	  contrast	  HSV	  latency	  features	  long-­‐term	  repression	  of	  the	  lytic	  program	  that	  may	  be	  punctuated	  by	  episodes	  of	  stress-­‐induced	  productive	  replication,	  termed	  reactivation.	  The	  lytic	  replicative	  cycle	  has	  been	  well	  defined	  [1],	  however	  the	  process	  by	  which	  HSV	  establishes	  and	  reactivates	  from	  latency	  is	  less	  clear.	  The	  difficulty	  in	  studying	  this	  aspect	  of	  HSV	  biology	  has	  primarily	  come	  from	  the	  lack	  of	  a	  suitable	  model	  to	  host	  experimental	  latency,	  as	  the	  virus	  has	  adapted	  to	  enter	  this	  state	  specifically	  within	  the	  environment	  of	  the	  human	  neuron.	  Current	  understanding	  of	  the	  molecular	  interplay	  between	  neuron	  and	  virus	  is	  discussed	  in	  this	  section,	  including	  a	  review	  of	  the	  available	  models	  of	  HSV	  latency	  and	  their	  limitations.	  	  	  
1.1 HSV	  pathogenesis	  	   HSV	  is	  a	  double-­‐stranded	  DNA	  virus	  that	  belongs	  to	  the	  Alphaherpesvirinae	  subfamily	  of	  Herpesviridae	  and	  is	  a	  pathogen	  of	  humans.	  As	  with	  other	  alphaherpesviruses	  HSV	  employs	  two	  distinct	  infectious	  cycles	  in	  its	  host:	  a	  productive	  or	  lytic	  cycle	  that	  takes	  place	  in	  mucoepithelial	  tissues	  (described	  in	  [1]),	  and	  a	  latency-­‐reactivation	  cycle	  restricted	  to	  sensory	  neurons	  of	  the	  peripheral	  nervous	  system	  [1].	  When	  HSV	  encounters	  a	  naïve	  host	  lytic	  replication	  occurs	  at	  the	  body	  surface,	  often	  resulting	  in	  development	  of	  characteristic	  lesions.	  Production	  of	  viral	  progeny	  at	  this	  site	  feeds	  the	  establishment	  of	  latency	  as	  innervating	  sensory	  neurons	  are	  infected	  at	  the	  axon	  terminus.	  Inside	  the	  neuron	  the	  virus	  enters	  latency,	  which	  may	  be	  maintained	  for	  the	  life	  of	  the	  host	  with	  intermittent	  episodes	  of	  viral	  reactivation.	  HSV	  reactivation	  can	  be	  induced	  by	  a	  variety	  of	  stress	  stimuli,	  and	  features	  the	  reemergence	  of	  infectious	  virus	  from	  the	  neuron	  at	  the	  axon	  terminus	  and	  infection	  of	  epithelial	  cells	  at	  this	  site.	  The	  frequency	  and	  severity	  of	  recrudescent	  infection	  varies	  between	  individuals	  and	  is	  thought	  to	  depend	  on	  factors	  such	  as	  genetic	  differences	  in	  the	  immune	  system.	  The	  success	  of	  establishing	  a	  latent	  reservoir	  is	  demonstrated	  by	  high	  seroprevalence	  rates	  of	  HSV	  in	  the	  human	  population	  [2].	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1.2 Lytic	  replication	  	   While	  productive	  HSV	  infection	  occurs	  primarily	  in	  the	  mucoepithelial	  tissue	  of	  human	  hosts,	  the	  virus	  can	  successfully	  replicate	  in	  an	  extensive	  range	  of	  cell	  types	  in	  vitro,	  including	  epithelial,	  fibroblast,	  and	  tumour	  cells	  from	  multiple	  species	  (reviewed	  in	  [3]).	  The	  molecular	  process	  behind	  lytic	  HSV	  replication	  has	  been	  well	  described	  (see	  [1])	  and	  proceeds	  by	  a	  sequential	  cascade	  of	  expression	  from	  three	  gene	  classes—immediate-­‐early	  (IE,	  α),	  early	  (E,	  β),	  and	  late	  (L,	  γ).	  Gene	  expression	  is	  initiated	  following	  viral	  entry	  and	  nuclear	  inoculation	  by	  the	  viral	  protein	  VP16,	  which	  is	  imported	  into	  the	  cell	  as	  a	  preformed	  component	  of	  the	  virion.	  The	  VP16-­‐induced	  complex	  (VIC)	  is	  comprised	  of	  VP16	  and	  two	  cellular	  cofactors,	  host	  cell	  factor	  C1	  (HCF)	  and	  the	  POU	  domain	  octamer	  transcription	  factor	  1	  (Oct-­‐1),	  and	  binds	  a	  recognition	  sequence	  in	  the	  IE	  gene	  promoters	  to	  initiate	  their	  transcription	  [4].	  Proteins	  translated	  from	  the	  IE	  class	  genes	  direct	  and	  enhance	  viral	  replication	  and	  assembly,	  as	  well	  as	  counteract	  repression	  of	  the	  virus	  by	  the	  cell	  [5].	  IE	  proteins	  activate	  expression	  of	  the	  early	  gene	  class,	  which	  encodes	  machinery	  for	  replicating	  the	  viral	  genome.	  Synthesis	  of	  the	  early	  proteins	  and	  viral	  DNA	  replication	  are	  followed	  by	  activation	  of	  expression	  from	  the	  late	  gene	  class.	  The	  late	  genes	  typically	  encode	  structural	  capsid	  proteins	  and	  proteins	  that	  must	  be	  carried	  with	  the	  virion	  to	  initiate	  infection	  in	  a	  naïve	  cell	  [1].	  The	  VP16	  protein	  is	  synthesized	  as	  a	  late	  gene	  product	  and	  is	  assembled	  into	  the	  capsids	  of	  progeny	  virus	  prior	  to	  egress	  from	  the	  cell	  [6,	  7].	  The	  finding	  that	  HSV	  lytic	  replication	  is	  driven	  by	  VP16,	  a	  late	  gene	  product,	  has	  complicated	  the	  understanding	  of	  how	  reactivation	  from	  latency	  occurs,	  as	  expression	  of	  all	  lytic	  gene	  classes	  depends	  on	  the	  presence	  of	  earlier	  gene	  class	  products.	  	  	   	  As	  with	  most	  viruses,	  many	  aspects	  of	  the	  cellular	  environment	  are	  altered	  by	  HSV	  to	  facilitate	  its	  successful	  replication.	  Host	  protein	  synthesis	  is	  attenuated	  through	  degradation	  of	  cellular	  mRNA	  [8],	  and	  interference	  with	  innate	  immune	  function	  allows	  for	  evasion	  of	  host	  defenses	  (reviewed	  in	  [9]).	  Attempts	  by	  the	  cell	  to	  repress	  the	  incoming	  virus	  through	  intrinsic	  mechanisms,	  such	  as	  epigenetic	  silencing,	  are	  also	  counteracted	  by	  HSV	  during	  the	  early	  stages	  of	  replication	  (reviewed	  in	  [10]).	  Proper	  function	  of	  viral	  regulatory	  proteins	  that	  enact	  these	  processes	  is	  important	  to	  successful	  replication,	  and	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how	  these	  actions	  are	  circumvented	  in	  the	  establishment	  of	  latency	  is	  key	  to	  understanding	  the	  dual	  life	  cycle	  of	  HSV.	  
1.3 The	  latency-­‐reactivation	  cycle	  	   Latent	  HSV	  infection	  occurs	  in	  sensory	  neurons	  and	  can	  be	  broken	  into	  three	  phases:	  establishment,	  where	  the	  virus	  infects	  the	  neuron	  and	  transitions	  into	  the	  latent	  state;	  maintenance,	  where	  the	  virus	  remains	  dormant	  inside	  the	  neuron	  nucleus;	  and	  reactivation,	  where	  the	  virus	  is	  stimulated	  to	  exit	  latency	  and	  produce	  infectious	  progeny.	  HSV	  latency	  is	  defined	  by	  the	  presence	  of	  viral	  DNA	  in	  the	  absence	  of	  infectious	  virus	  and	  without	  transcription	  of	  the	  lytic	  program,	  and	  the	  ability	  to	  provoke	  reactivation	  from	  this	  persistent	  DNA.	  No	  single	  mechanism	  has	  been	  identified	  as	  the	  mediator	  of	  entrance	  into	  or	  exit	  from	  latency,	  and	  the	  latency-­‐reactivation	  cycle	  may	  be	  regarded	  as	  the	  sum	  of	  several	  interactions	  between	  virus	  and	  neuron.	  Current	  dogma	  posits	  that	  HSV	  latency	  is	  heterogeneous	  in	  nature,	  where	  the	  virus	  is	  maintained	  in	  a	  more	  or	  less	  repressed	  state	  dependent	  on	  the	  environment	  of	  the	  neuron	  it	  inhabits.	  Viral	  reactivation,	  provoked	  by	  the	  cellular	  response	  to	  stress,	  is	  similarly	  viewed	  as	  a	  process	  dependent	  on	  the	  intensity	  of	  stress	  and	  number	  of	  available	  viral	  genomes.	  Molecular	  mechanisms	  involved	  in	  navigation	  of	  the	  HSV	  latency-­‐reactivation	  cycle	  are	  summarized	  in	  Figure	  1.1	  and	  Figure	  1.3.	  
1.3.1 Establishment	  and	  maintenance	  of	  latency	  
1.3.1.1 The	  environment	  at	  the	  site	  of	  latency:	  Physical	  differences	  in	  the	  environment	  encountered	  by	  HSV	  upon	  entry	  into	  a	  neuron	  versus	  epithelial	  cell	  may	  contribute	  to	  initiation	  of	  viral	  latency	  versus	  lytic	  replication.	  Upon	  entry	  of	  the	  virus	  into	  the	  neuron,	  the	  first	  barrier	  to	  initiating	  lytic	  infection	  is	  navigating	  transport	  from	  the	  axon	  terminus	  to	  the	  cell	  body	  and	  nucleus.	  While	  VP16	  is	  readily	  detected	  in	  the	  nucleus	  of	  productively	  infected	  cells,	  several	  studies	  have	  demonstrated	  that	  this	  protein	  dissociates	  from	  the	  virus	  prior	  to	  retrograde	  axonal	  transport	  [11,	  12].	  As	  the	  site	  of	  viral	  entry	  has	  been	  shown	  to	  be	  a	  determinant	  of	  the	  nuclear	  presence	  of	  VP16	  [13]	  and	  thus	  initiation	  of	  IE	  gene	  expression,	  this	  represents	  a	  key	  factor	  in	  the	  decision	  between	  productive	  infection	  and	  genome	  silencing.	  A	  second	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barrier	  to	  activation	  of	  the	  lytic	  program	  is	  the	  extranuclear	  localization	  of	  HCF	  specifically	  in	  neurons.	  In	  latently	  infected	  sensory	  neurons	  HCF	  is	  tethered	  to	  the	  Golgi	  apparatus	  [14],	  physically	  separated	  from	  the	  virus	  in	  the	  nucleus.	  In	  addition,	  a	  reported	  low	  abundance	  of	  Oct-­‐1	  in	  mature	  neurons	  [15]	  and	  an	  inability	  of	  other	  POU-­‐domain	  transcription	  factors	  to	  substitute	  for	  Oct-­‐1	  in	  HSV	  transcription	  initiation	  [16,	  17]	  suggest	  yet	  a	  third	  barrier	  to	  assembling	  the	  VIC	  in	  neurons.	  Despite	  these	  findings	  HSV	  is	  known	  to	  undergo	  an	  acute	  phase	  of	  productive	  replication	  in	  the	  trigeminal	  ganglia	  (TG)	  [18,	  19],	  and	  populations	  of	  neurons	  that	  have	  experienced	  lytic	  gene	  expression	  prior	  to	  latency	  establishment	  are	  detectable	  [20,	  21].	  These	  results	  suggest	  that	  partial	  progression	  through	  the	  lytic	  program	  has	  a	  limited	  effect	  on	  the	  ability	  of	  HSV	  to	  enter	  latency,	  however	  the	  significance	  of	  these	  observations	  in	  view	  of	  the	  neuronal	  barriers	  to	  VIC	  assembly	  is	  not	  well	  resolved.	  The	  subtype	  of	  neuron	  encountered	  by	  the	  incoming	  virus	  may	  also	  play	  a	  role	  in	  how	  latent	  infection	  is	  established.	  This	  is	  indicated	  by	  the	  observation	  that	  latency	  is	  preferentially	  established	  in	  distinct	  populations	  of	  neurons,	  despite	  the	  susceptibility	  of	  all	  neurons	  to	  infection	  [22,	  23].	  Latency-­‐prone	  neuron	  populations	  are	  nerve	  growth	  factor	  (NGF)-­‐responsive	  nociceptors	  that	  display	  a	  characteristic	  pattern	  of	  immunoreactivity	  [22,	  24],	  however	  these	  biochemical	  properties	  have	  not	  been	  linked	  mechanistically	  to	  HSV	  latency.	  Variation	  in	  HSV	  copy	  number	  between	  the	  neurons	  of	  infected	  ganglia	  also	  supports	  the	  notion	  of	  neuron-­‐specific	  differences	  making	  important	  contributions	  to	  the	  fate	  of	  the	  virus	  [25].	  Collectively	  these	  reports	  illustrate	  that	  the	  physiology	  and	  biochemistry	  of	  the	  infected	  neuron	  is	  important	  to	  the	  process	  of	  establishing	  HSV	  latency.	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Figure	  1.1.	  Contributing	  factors	  in	  the	  establishment	  of	  HSV	  latency.	  	  HSV	  latency	  is	  preferentially	  established	  within	  the	  neuron.	  a)	  following	  viral	  entry,	  capsid	  proteins,	  including	  VP16,	  are	  lost	  prior	  to	  axonal	  transport	  to	  the	  nucleus.	  b)	  physiological	  and	  biochemical	  differences	  between	  neuron	  subtypes	  influence	  HSV	  to	  enter	  latency	  or	  undergo	  lytic	  replication	  in	  the	  nucleus.	  c)	  the	  absence	  of	  VIC	  components	  in	  the	  nucleus	  impair	  induction	  of	  the	  lytic	  program.	  d)	  cellular	  epigenetic	  mechanisms	  load	  repressive	  chromatin	  onto	  the	  virus,	  silencing	  the	  lytic	  program	  and	  transitioning	  the	  virus	  into	  latency.	  Image	  credits:	  neuron	  adapted	  from	  [26],	  nucleosomes	  adapted	  from	  [27].	  
1.3.1.2 Transitioning	  into	  latency:	  Transition	  of	  HSV	  into	  the	  latent	  state	  involves	  changes	  in	  both	  the	  conformation	  of	  the	  viral	  genome	  and	  its	  association	  with	  cellular	  proteins.	  HSV	  is	  known	  to	  circularize	  as	  an	  episome	  following	  nuclear	  import	  [28],	  a	  process	  that	  facilitates	  long-­‐term	  persistence	  in	  the	  host	  cell.	  In	  addition	  to	  this	  conformational	  change,	  the	  incoming	  virus	  is	  loaded	  with	  histones	  and	  gradually	  packaged	  into	  a	  secondary	  organization	  resembling	  cellular	  heterochromatin	  [29].	  HSV	  genomes	  entering	  the	  nucleus	  localize	  to	  nuclear	  domain	  10	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(ND10)	  structures,	  which	  contain	  protein	  effectors	  that	  cooperatively	  repress	  viral	  gene	  expression	  [30]	  as	  well	  as	  modulate	  cellular	  chromatin	  dynamics	  [31].	  As	  entrance	  into	  latency	  progresses,	  histones	  associated	  with	  the	  HSV	  genome	  accumulate	  marks	  of	  transcriptional	  silencing	  [32].	  A	  hallmark	  of	  HSV	  latency	  is	  the	  absence	  of	  lytic	  program	  transcription,	  and	  while	  some	  degree	  of	  lytic	  gene	  expression	  may	  occur	  during	  establishment	  [20,	  33],	  once	  the	  virus	  has	  transitioned	  into	  the	  latent	  state	  transcriptional	  silence	  prevails.	  
1.3.1.3 Maintaining	  latency:	  Once	  HSV	  has	  transitioned	  into	  a	  latent	  state	  the	  virus	  can	  persist	  in	  the	  neuron	  indefinitely,	  maintained	  by	  signals	  from	  the	  virus,	  cell,	  and	  immune	  system.	  By	  utilizing	  input	  from	  these	  sources	  to	  enforce	  latency,	  the	  virus	  is	  attuned	  to	  changes	  in	  its	  environment	  that	  may	  signal	  a	  need	  to	  initiate	  reactivation.	  	  One	  exception	  to	  long-­‐term	  transcriptional	  silencing	  of	  HSV	  in	  latency	  is	  the	  region	  of	  the	  latency	  associated	  transcript	  (LAT),	  an	  active	  locus	  segregated	  from	  the	  repressive	  chromatin	  on	  the	  remainder	  of	  the	  genome	  [34].	  The	  primary	  LAT	  is	  an	  8.3kb	  RNA	  transcript	  that	  is	  processed	  to	  yield	  smaller	  functional	  RNA	  products	  [35],	  as	  well	  as	  microRNA	  species	  [36].	  This	  transcript	  has	  been	  ascribed	  many	  functions	  during	  latency,	  however	  none	  are	  an	  absolute	  requirement	  for	  latency	  and	  reactivation	  to	  occur:	  the	  phenotype	  of	  LAT-­‐deleted	  viral	  mutants	  differs	  between	  models	  but	  the	  ability	  to	  establish	  latency	  and	  reactivate	  is	  generally	  retained	  [25,	  37].	  No	  LAT	  protein	  has	  been	  reliably	  detected,	  and	  the	  transcript	  is	  accepted	  to	  function	  as	  a	  regulatory	  RNA.	  It	  has	  been	  indicated	  that	  some	  products	  of	  the	  primary	  transcript	  act	  through	  RNA	  interference	  pathways	  [38,	  39],	  while	  other	  products	  may	  effect	  epigenetic	  silencing	  in	  a	  manner	  similar	  to	  other	  long	  non-­‐coding	  RNAs	  [40].	  The	  most	  clearly	  defined	  function	  of	  the	  LAT	  is	  its	  ability	  to	  protect	  infected	  cells	  from	  apoptosis	  [41].	  The	  presence	  of	  a	  functional	  LAT	  region	  is	  associated	  with	  decreased	  apoptosis	  during	  HSV	  infection	  [42],	  and	  the	  LAT	  deletion	  phenotype	  can	  be	  rescued	  by	  introducing	  a	  cellular	  anti-­‐apoptotic	  gene	  [43].	  Expression	  of	  the	  LAT	  has	  also	  been	  found	  to	  vary	  between	  neurons	  carrying	  latent	  HSV	  [44,	  45],	  alluding	  to	  the	  heterogeneous	  nature	  of	  HSV	  latency.	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Cellular	  signaling	  also	  plays	  a	  role	  in	  maintaining	  HSV	  latency,	  and	  signaling	  pathways	  stimulated	  by	  the	  presence	  of	  certain	  growth	  factors	  have	  been	  shown	  to	  regulate	  the	  decision	  between	  latency	  and	  reactivation.	  Withdrawal	  of	  NGF	  from	  ex	  vivo	  cultured	  neurons	  has	  long	  been	  known	  to	  induce	  reactivation	  of	  latent	  HSV	  [46].	  It	  has	  since	  been	  determined	  that	  NGF-­‐mediated	  activation	  of	  the	  receptor	  tyrosine	  kinase	  TrkA	  results	  in	  stimulation	  of	  Akt,	  a	  cellular	  protein	  involved	  in	  a	  myriad	  of	  signaling	  pathways,	  and	  that	  active	  signaling	  through	  this	  network	  is	  required	  to	  maintain	  HSV	  latency	  [47].	  This	  work	  has	  demonstrated	  how	  input	  from	  the	  cell	  reinforces	  the	  latent	  state,	  sensitizing	  the	  virus	  to	  disruptions	  in	  the	  availability	  of	  growth	  factors	  via	  cell	  signaling	  cascades.	  	  	   The	  influence	  of	  the	  immune	  system	  is	  additionally	  known	  to	  play	  a	  role	  in	  the	  maintenance	  of	  HSV	  latency.	  Latently	  infected	  ganglia	  attract	  CD8+	  T	  cells	  [48],	  which	  have	  been	  shown	  to	  strongly	  inhibit	  viral	  replication	  via	  nonlethal	  administration	  of	  interferon	  gamma	  and	  granzyme	  B	  to	  the	  neuron	  [49].	  The	  LAT	  may	  participate	  in	  protecting	  infected	  neurons	  from	  the	  cytotoxic	  effects	  of	  infiltrating	  CD8+	  T	  cells	  [50],	  indicating	  yet	  another	  level	  of	  regulatory	  virus-­‐cell	  interaction	  in	  latency.	  Other	  immune	  cytokines,	  such	  as	  interferon	  alpha,	  have	  also	  been	  reported	  to	  aid	  in	  the	  development	  and	  maintenance	  of	  latency	  [51].	  This	  presents	  a	  mechanism	  by	  which	  HSV	  latency	  is	  maintained	  via	  forces	  external	  to	  the	  neuronal	  environment,	  allowing	  the	  virus	  to	  include	  the	  state	  of	  the	  host	  organism	  in	  the	  decision	  between	  maintaining	  latency	  and	  reactivation.	  
1.3.2 Reactivation	  	   In	  humans,	  latent	  infection	  is	  punctuated	  by	  episodes	  of	  reactivation	  which	  culminate	  in	  production	  and	  spread	  of	  infectious	  virus	  at	  the	  body	  surface.	  HSV	  reactivation	  frequently	  follows	  the	  experience	  of	  stress,	  such	  as	  sunburn,	  fever,	  immune	  compromise,	  or	  psychological	  distress	  [1].	  While	  the	  relationship	  between	  the	  virus	  and	  the	  stress	  response	  is	  clear	  at	  the	  level	  of	  the	  organism,	  how	  latent	  HSV	  interfaces	  with	  the	  cellular	  environment	  to	  initiate	  reactivation	  at	  the	  molecular	  level	  remains	  obscure.	  What	  is	  becoming	  clear	  is	  that	  cell	  survival	  pathways	  are	  involved	  in	  the	  induction	  of	  reactivation,	  and	  that	  transition	  of	  the	  HSV	  genome	  from	  latency	  to	  transcriptional	  activity	  and	  replication	  is	  the	  sum	  of	  several	  contributing	  factors.	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1.3.2.1 Cellular	  events	  leading	  to	  HSV	  reactivation:	   	  Clues	  to	  cellular	  pathways	  that	  enable	  the	  exit	  of	  HSV	  from	  latency	  have	  come	  from	  agents	  that	  induce	  reactivation	  in	  an	  experimental	  setting.	  NGF	  withdrawal,	  neuronal	  explant,	  transient	  heat	  shock,	  and	  treatment	  with	  histone	  deacetylase	  (HDAC)	  inhibitors	  are	  some	  of	  the	  classical	  methods	  by	  which	  reactivation	  has	  been	  stimulated	  from	  experimental	  HSV	  latency	  [1].	  The	  success	  of	  these	  treatments	  in	  inducing	  reactivation	  points	  to	  stress	  response	  and	  cell	  survival	  pathways	  as	  being	  influential	  in	  provoking	  the	  latent	  virus	  to	  reactivate.	  The	  most	  well	  defined	  cellular	  mechanism	  that	  stimulates	  HSV	  reactivation	  is	  induced	  by	  withdrawal	  of	  NGF	  from	  latently	  infected	  neurons	  [46].	  Removal	  of	  NGF	  shuts	  off	  signaling	  through	  the	  TrkA	  receptor	  and	  leads	  to	  inhibition	  of	  Akt	  activity	  (Figure	  1.2),	  an	  event	  sufficient	  to	  induce	  reactivation	  [47].	  Farther	  downstream	  in	  the	  response	  to	  NGF	  deprivation	  is	  the	  induction	  of	  the	  caspase	  cascade	  [52],	  which	  has	  also	  been	  indicated	  as	  a	  key	  regulatory	  point	  in	  effecting	  HSV	  reactivation	  [53]	  (Figure	  1.2).	  Less	  is	  known	  about	  the	  mechanisms	  involved	  in	  stimulating	  reactivation	  via	  other	  methods,	  such	  as	  heat	  shock,	  partly	  due	  to	  the	  global	  changes	  involved	  in	  enacting	  the	  stress	  response	  [54].	  In	  the	  case	  of	  a	  response	  involving	  vast	  transcriptional	  changes	  it	  is	  conceivable	  that	  the	  HSV	  lytic	  program	  becomes	  active	  alongside	  upregulated	  cellular	  genes.	  This	  idea	  is	  consistent	  with	  the	  observation	  that	  histones	  associated	  with	  the	  lytic	  viral	  promoters	  accumulate	  marks	  of	  activated	  transcription	  following	  exposure	  to	  reactivation	  stimuli	  [55,	  56].	  Additionally,	  suppression	  or	  loss	  of	  the	  pro-­‐latency	  influence	  of	  the	  immune	  system	  could	  contribute	  to	  successful	  reactivation	  through	  alleviating	  repression	  of	  the	  virus	  [57].	  The	  scope	  of	  cellular	  processes	  that	  enable	  HSV	  reactivation	  has	  not	  been	  defined	  beyond	  this	  rudimentary	  understanding	  however,	  and	  the	  contribution	  of	  these	  pathways	  to	  human	  recrudescent	  disease	  is	  not	  yet	  clear.	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Figure	  1.2	  Cellular	  pathways	  leading	  to	  HSV	  reactivation	  HSV	  reactivation	  is	  induced	  by	  removal	  of	  NGF.	  In	  the	  absence	  of	  NGF	  the	  receptor	  tyrosine	  kinase	  TrkA	  does	  not	  dimerize	  and	  PI3K	  activation	  does	  not	  occur.	  Owing	  to	  PI3K	  shutoff,	  Akt	  is	  inactive.	  Disruption	  of	  TrkA,	  PI3K	  or	  Akt	  activity	  is	  sufficient	  to	  induce	  reactivation	  [47],	  however	  downstream	  effectors	  linking	  this	  pathway	  to	  the	  HSV	  genome	  have	  not	  yet	  been	  elucidated.	  It	  has	  been	  demonstrated	  that	  caspase	  3	  activation	  in	  response	  to	  NGF	  deprivation	  is	  necessary	  for	  efficient	  HSV	  reactivation	  [53],	  however	  the	  relationship	  of	  caspase	  3	  activation	  to	  other	  cellular	  signaling	  pathways	  in	  this	  instance	  is	  not	  yet	  clear.	  	   Following	  exposure	  to	  stress	  stimuli,	  certain	  physiological	  changes	  in	  the	  neuron	  take	  place	  that	  may	  favour	  successful	  viral	  reactivation.	  One	  such	  event	  is	  the	  relocalization	  of	  HCF	  to	  the	  nucleus	  in	  response	  to	  stress	  [58],	  where	  it	  further	  localizes	  to	  the	  HSV	  IE	  promoters	  [59].	  HCF	  is	  known	  to	  recruit	  chromatin	  remodeling	  machinery	  to	  remove	  repressive	  histone	  marks	  from	  the	  HSV	  genome	  [60],	  and	  this	  interaction	  may	  be	  important	  for	  reactivation	  to	  proceed.	  Oct-­‐1	  induction	  has	  been	  reported	  following	  exposure	  to	  noxious	  stimuli	  [61],	  providing	  a	  potential	  means	  of	  overcoming	  low	  levels	  of	  this	  cofactor	  in	  the	  neuron.	  Collectively	  these	  reports	  demonstrate	  a	  stress-­‐dependent	  reorganization	  of	  the	  theorized	  barriers	  to	  initiating	  lytic	  replication	  in	  the	  neuron	  nucleus,	  resulting	  in	  an	  environment	  more	  permissive	  to	  the	  productive	  cycle.	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1.3.2.2 Viral	  response	  to	  reactivation	  stimuli:	  	   Two	  contemporary	  theories	  have	  arisen	  on	  how	  latent	  HSV	  navigates	  the	  transition	  from	  latency	  to	  transcriptional	  activity	  and	  replication.	  One	  theory	  posits	  that	  the	  cellular	  stress	  response	  induces	  transcription	  from	  all	  responsive	  viral	  genes,	  generating	  a	  pool	  of	  viral	  proteins	  that	  mediate	  lytic	  cycle	  re-­‐entry	  [62].	  Central	  to	  this	  theory	  is	  the	  idea	  that	  in	  reactivation	  the	  lytic	  replicative	  cycle	  is	  restarted	  at	  the	  point	  of	  IE	  gene	  induction.	  This	  is	  supported	  by	  the	  observation	  that,	  following	  reactivation	  stimuli,	  transcription	  from	  all	  temporal	  gene	  classes	  proceeds	  in	  the	  absence	  of	  viral	  protein	  synthesis	  [62,	  63].	  The	  finding	  that	  several	  viral	  promoters	  are	  induced	  by	  the	  stress	  response	  is	  also	  consistent	  with	  concurrent	  induction	  of	  lytic	  genes	  by	  cellular	  factors	  [64].	  An	  alternate	  theory	  posits	  that	  VP16	  expression	  is	  specifically	  induced	  by	  the	  cellular	  stress	  response	  and	  that	  this	  event	  initiates	  exit	  from	  latency	  [65].	  Support	  for	  this	  theory	  comes	  from	  the	  observation	  that	  in	  the	  absence	  of	  a	  functional	  VP16	  activation	  domain	  reactivation	  does	  not	  proceed	  past	  VP16	  promoter	  induction	  [65].	  To	  unite	  the	  results	  supporting	  these	  two	  theories,	  a	  model	  has	  been	  proposed	  wherein	  the	  cellular	  stress	  response	  elicits	  an	  “animation”	  phase	  from	  the	  virus	  [63].	  During	  animation,	  repression	  is	  alleviated	  and	  HSV	  mRNA	  is	  synthesized	  from	  all	  gene	  classes	  without	  adherence	  to	  the	  lytic	  expression	  cascade	  [63].	  This	  may	  be	  followed	  by	  a	  second	  phase,	  with	  progression	  being	  determined	  by	  factors	  such	  as	  the	  intensity	  of	  the	  stress	  response	  versus	  availability	  of	  mechanisms	  that	  can	  return	  the	  animated	  virus	  to	  a	  repressed	  state.	  In	  the	  second	  phase,	  factors	  required	  for	  activation	  of	  the	  IE	  genes	  by	  the	  VIC	  become	  available	  in	  the	  nucleus	  [63],	  and	  the	  majority	  of	  latent	  HSV	  genomes	  will	  progress	  to	  productive	  infection.	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Figure	  1.3.	  Factors	  governing	  HSV	  reactivation	  from	  latency.	  HSV	  reactivation	  in	  latently	  infected	  neurons	  occurs	  in	  response	  to	  stress.	  a)	  the	  process	  of	  reactivation	  is	  provoked	  by	  the	  experience	  of	  stress	  by	  the	  host.	  Exit	  from	  latency	  is	  coordinated	  by	  several	  molecular	  events:	  b)	  cellular	  stress	  response	  effectors	  induce	  transcription	  from	  the	  latent	  HSV	  genome.	  c)	  physiological	  changes,	  such	  as	  the	  relocalization	  of	  HCF	  to	  the	  nucleus,	  overcome	  barriers	  to	  initiating	  productive	  infection.	  d)	  the	  virus	  undergoes	  an	  animation	  phase,	  where	  transcription	  occurs	  without	  requirement	  for	  prior	  viral	  protein	  synthesis	  and	  VP16	  is	  manufactured.	  d)	  the	  lytic	  gene	  expression	  cascade	  is	  re-­‐entered	  at	  the	  point	  of	  VIC	  initiation	  of	  immediate	  early	  genes.	  Image	  credits:	  neuron	  adapted	  from	  [26],	  nucleosomes	  adapted	  from	  [27].	  
1.4 Models	  of	  HSV	  latency	  	   A	  common	  thread	  in	  HSV	  latency	  research	  is	  that	  the	  type	  of	  model	  employed	  influences	  how	  experimental	  results	  are	  interpreted.	  There	  exists	  a	  question	  of	  which	  experimental	  latency	  scenarios	  can	  be	  considered	  relevant	  to	  human	  HSV	  infection,	  and	  this	  interferes	  with	  determining	  parts	  of	  the	  latency-­‐reactivation	  cycle	  that	  may	  be	  vulnerable	  to	  intervention	  or	  useful	  as	  a	  platform	  for	  other	  therapies.	  Studying	  HSV	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reactivation	  in	  the	  human	  neuron	  has	  been	  possible	  only	  in	  limited	  circumstances—such	  as	  human	  ganglia	  obtained	  at	  autopsy—and	  as	  such,	  a	  reasonable	  facsimile	  of	  the	  neuronal	  environment	  in	  which	  to	  study	  the	  virus	  has	  been	  long	  sought.	  Current	  approaches	  for	  the	  study	  of	  HSV	  latency	  utilize	  small	  animal	  models,	  cultures	  of	  extracted	  primary	  neurons	  or	  neurons	  derived	  from	  pluripotent	  cells,	  cell	  culture	  models,	  or	  some	  variation	  thereof.	  	  
1.4.1.1 Small	  animal	  models:	  	   With	  certain	  limitations	  HSV	  latency	  can	  be	  modeled	  in	  laboratory	  animals,	  with	  the	  bulk	  of	  this	  research	  being	  performed	  in	  the	  mouse.	  The	  benefit	  of	  utilizing	  small	  animal	  models	  lies	  in	  the	  ability	  to	  simulate	  the	  natural	  course	  of	  HSV	  infection,	  with	  lytic	  infection	  at	  the	  body	  surface	  feeding	  establishment	  of	  a	  latent	  reservoir	  in	  the	  TG.	  However,	  issues	  of	  host	  restriction	  [66]	  and	  the	  inherently	  complex	  nature	  of	  studying	  molecular	  events	  in	  an	  animal	  model	  complicate	  this	  approach.	  The	  latency-­‐reactivation	  cycle	  is	  specifically	  adapted	  to	  human	  neurons,	  and	  as	  infection	  in	  the	  mouse	  model	  does	  not	  follow	  the	  same	  course	  as	  in	  humans,	  the	  resemblance	  of	  HSV	  latency	  between	  the	  two	  species	  has	  been	  questioned	  (reviewed	  in	  [67]).	  The	  course	  of	  HSV	  infection	  in	  the	  rabbit	  model	  more	  closely	  approximates	  human	  disease,	  including	  features	  such	  as	  spontaneous	  viral	  shedding	  that	  are	  absent	  from	  HSV	  pathogenesis	  in	  the	  mouse	  [67].	  While	  the	  number	  of	  studies	  is	  relatively	  small,	  HSV	  latency	  research	  performed	  in	  rabbits	  has	  challenged	  findings	  from	  the	  mouse	  model—for	  example	  the	  converse	  finding	  that	  in	  rabbits	  the	  LAT	  facilitates	  transcriptional	  permissiveness	  of	  the	  lytic	  genes	  [68].	  Small	  animal	  models	  are	  generally	  not	  well-­‐suited	  to	  molecular	  studies	  owing	  to	  limitations	  in	  manipulation	  and	  sensitivity.	  Isolating	  events	  contributing	  to	  HSV	  latency	  and	  reactivation	  in	  infected	  animals	  has	  therefore	  relied	  on	  elegant	  experimental	  design.	  The	  use	  of	  viral	  recombinants	  which	  mark	  infected	  neurons	  according	  to	  promoter	  activation	  [65,	  69],	  and	  the	  use	  of	  techniques	  to	  distinguish	  reactivating	  neurons	  in	  whole	  ganglia	  [70]	  have	  been	  able	  to	  overcome	  some	  of	  these	  limitations.	  
1.4.1.2 Models	  utilizing	  primary	  neurons:	  	   Methods	  using	  cultured	  primary	  neurons	  have	  also	  been	  developed	  to	  probe	  the	  mechanisms	  of	  HSV	  latency	  and	  reactivation.	  The	  oldest	  of	  these	  methods	  involves	  neuronal	  explant,	  in	  which	  ganglia	  of	  latently	  infected	  animals	  are	  excised	  and	  cultured	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[71].	  The	  benefit	  of	  this	  method	  is	  that	  explanted	  neurons	  can	  be	  manipulated	  in	  isolation	  from	  the	  animal,	  however	  the	  stress	  experienced	  by	  the	  cells	  during	  this	  procedure	  induces	  major	  physiological	  changes	  that	  would	  not	  be	  present	  during	  natural	  reactivation	  [72].	  A	  modification	  of	  the	  explant	  approach	  is	  to	  extract	  and	  dissociate	  primary	  neurons	  prior	  to	  infection	  with	  HSV	  [73].	  This	  allows	  for	  better	  control	  of	  the	  infection	  and	  reactivation	  process,	  and	  has	  been	  an	  important	  tool	  for	  deciphering	  virus-­‐cell	  interactions.	  This	  method	  remains	  limited	  by	  the	  issue	  of	  host	  restriction,	  however,	  and	  inhibition	  of	  viral	  replication	  (achieved	  by	  the	  use	  of	  antiviral	  drugs	  or	  viral	  mutants)	  is	  a	  prerequisite	  for	  latency	  establishment.	  In	  an	  eloquent	  variation,	  animal	  neurons	  grown	  in	  dual	  chamber	  systems	  separating	  the	  axon	  from	  cell	  body	  have	  been	  used	  to	  recover	  the	  contributions	  of	  viral	  entry	  at	  the	  axon	  terminus	  [51].	  This	  chambered	  system	  obviates	  the	  need	  for	  replication	  inhibition,	  and	  is	  a	  powerful	  tool	  for	  studying	  the	  latency-­‐reactivation	  cycle.	  
1.4.1.3 Cell	  culture	  models:	  	   Owing	  to	  their	  ease	  of	  use,	  a	  variety	  of	  cultured	  cell	  models	  have	  been	  developed	  to	  host	  experimental	  HSV	  latency—termed	  “quiescent	  infection”	  in	  the	  context	  of	  cell	  culture.	  The	  best	  described	  system	  utilizes	  PC-­‐12	  cells,	  a	  rat	  pheochromocytoma	  cell	  line	  that	  can	  be	  induced	  to	  develop	  a	  neuronal	  morphology	  by	  incubation	  with	  NGF	  [74].	  The	  method	  of	  establishing	  latent	  infection	  in	  differentiated	  PC-­‐12	  cells	  is	  similar	  to	  that	  of	  primary	  neuron	  cultures,	  where	  viral	  replication	  inhibition	  is	  required	  to	  develop	  a	  pool	  of	  quiescently	  infected	  cells	  suitable	  for	  reactivation	  studies	  [74].	  This	  approach	  of	  stimulating	  neuronal	  differentiation	  from	  a	  precursor	  cell	  has	  been	  attempted	  with	  the	  human	  NT2	  teratocarcinoma	  cell	  line	  [75],	  the	  human	  SH-­‐SY5Y	  neuroblastoma	  cell	  line	  [76],	  and	  most	  recently	  by	  using	  induced	  pluripotent	  stem	  cells	  (iPS)	  of	  human	  origin	  [77],	  however	  use	  of	  these	  differentiated	  cells	  as	  models	  of	  HSV	  latency	  has	  not	  been	  well	  characterized.	  To	  capture	  the	  mechanisms	  of	  viral	  repression	  at	  work	  in	  untransformed	  cells,	  quiescent	  infection	  in	  non-­‐neuronal	  human	  cells	  has	  also	  been	  explored,	  as	  in	  the	  case	  of	  normal	  human	  diploid	  fibroblasts	  [78].	  
1.4.1.4 Viral	  mutants	  in	  HSV	  latency	  models:	  Many	  studies	  seeking	  to	  decipher	  the	  HSV	  latency-­‐reactivation	  cycle	  have	  relied	  on	  the	  use	  of	  viral	  mutants,	  either	  to	  promote	  entrance	  into	  latency	  by	  artificially	  suppressing	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the	  lytic	  cycle	  or	  to	  determine	  the	  contribution	  of	  particular	  genes	  to	  HSV	  reactivation.	  The	  major	  viral	  trans-­‐activating	  proteins	  ICP0,	  ICP4,	  and	  VP16	  have	  most	  commonly	  been	  altered	  to	  facilitate	  development	  of	  a	  non-­‐productive	  infection	  [79-­‐82],	  and	  provided	  exogenously	  to	  stimulate	  reactivation	  [83,	  84].	  VP16	  and	  ICP4	  perform	  essential	  functions	  in	  production	  of	  infectious	  progeny	  [85,	  86],	  and	  deletion	  of	  either	  gene	  severely	  decreases	  the	  likelihood	  that	  the	  virus	  will	  progress	  through	  lytic	  replication.	  Functional	  VP16	  is	  essential	  during	  virion	  assembly	  and	  egress,	  however,	  specific	  disruption	  of	  the	  C-­‐terminal	  activation	  domain	  has	  permitted	  isolation	  of	  the	  contributions	  of	  VP16	  to	  IE	  gene	  transcription	  [87].	  VP16	  activation	  domain	  mutants	  have	  facilitated	  studies	  indicating	  the	  importance	  of	  this	  region	  in	  reactivation	  [65],	  particularly	  in	  response	  to	  stress	  [88].	  ICP0-­‐null	  mutants	  are	  frequently	  used	  in	  studies	  probing	  the	  effects	  of	  cellular	  antiviral	  mechanisms,	  as	  the	  absence	  of	  this	  protein	  exposes	  the	  viral	  genome	  to	  cell-­‐mediated	  repression	  at	  low	  multiplicities	  of	  infection	  [89].	  While	  ICP0	  is	  not	  essential	  for	  exiting	  latency,	  it	  is	  required	  for	  production	  of	  progeny	  virion	  [90]	  and	  can	  provoke	  even	  tightly	  repressed	  genomes	  to	  re-­‐enter	  the	  lytic	  cycle	  [78].	  The	  use	  of	  viral	  mutants	  has	  been	  invaluable	  to	  unraveling	  the	  HSV	  latency-­‐reactivation	  cycle	  within	  the	  model	  systems	  described	  by	  specifically	  identifying	  functional	  regions	  of	  the	  virus	  involved	  in	  each	  stage	  of	  its	  life	  cycle.	  
1.4.1.5 Contributions:	  Collectively,	  the	  various	  models	  used	  to	  unravel	  the	  mechanics	  of	  HSV	  latency	  and	  reactivation	  have	  generated	  a	  framework	  of	  how	  infection	  is	  expected	  to	  occur	  in	  a	  human	  host.	  Contributions	  from	  small	  animal	  models	  have	  yielded	  a	  broad	  understanding	  of	  factors	  involved	  in	  the	  latency-­‐reactivation	  cycle,	  while	  in	  vitro	  models	  have	  isolated	  the	  cellular	  and	  viral	  mechanisms	  at	  work.	  No	  model	  perfectly	  recapitulates	  the	  human	  neuron,	  although	  several	  animal	  models	  have	  been	  developed	  that	  are	  able	  to	  approximate	  this	  environment	  for	  the	  virus.	  With	  the	  majority	  of	  available	  models	  being	  derived	  from	  animals,	  there	  is	  both	  a	  need	  to	  confirm	  findings	  from	  these	  models	  within	  a	  human	  context	  and	  investigate	  the	  role	  of	  human	  neuron-­‐specific	  factors.	  To	  address	  this	  need,	  human	  cell	  lines	  established	  from	  neuronal	  precursor	  cells—in	  a	  manner	  similar	  to	  the	  differentiated	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PC-­‐12	  cell	  model—may	  prove	  useful	  by	  linking	  the	  human	  and	  neuronal	  requirements	  of	  the	  virus.	  	  
1.5 Medulloblastomas	  	   Medulloblastomas	  are	  malignant	  primary	  central	  nervous	  system	  tumours	  diagnosed	  most	  often	  in	  children.	  They	  are	  a	  heterogeneous	  class	  of	  tumours	  thought	  to	  arise	  from	  various	  derangements	  in	  the	  developmental	  program	  of	  the	  cerebellum.	  Current	  theory	  on	  the	  carcinogenesis	  of	  medulloblastomas	  posits	  that	  proliferating	  neural	  progenitor	  cells	  suffer	  a	  deregulation	  of	  pathways	  crucial	  for	  normal	  transition	  into	  differentiated	  cells,	  and	  this	  allows	  for	  aberrant	  expansion	  of	  the	  cell	  population	  (reviewed	  in	  [91,	  92]).	  Several	  subclasses	  of	  medulloblastoma	  exist,	  with	  inappropriate	  activation	  of	  Shh	  and	  Wnt	  pathways	  known	  to	  drive	  formation	  of	  these	  tumours	  [93,	  94].	  	   Medulloblastoma	  cell	  lines	  are	  known	  to	  develop	  the	  characteristics	  of	  neuronal	  or	  glial	  cells	  when	  exposed	  to	  differentiating	  agents	  [95,	  96],	  although	  the	  capacity	  for	  differentiation	  varies	  with	  cell	  line	  and	  treatment	  [97].	  Differentiation	  is	  typically	  characterized	  by	  the	  presence	  or	  absence	  of	  proteins	  specific	  to	  cells	  of	  either	  neuronal	  or	  glial	  lineage.	  There	  has	  been	  little	  investigation	  to	  define	  the	  differentiated	  medulloblastoma	  cell	  and	  its	  usefulness	  as	  a	  model,	  in	  contrast	  to	  the	  wealth	  of	  studies	  performed	  on	  other	  nervous	  system	  tumour	  cell	  lines	  (such	  as	  the	  SH-­‐SY5Y	  neuroblastoma	  cell	  line)	  in	  both	  differentiated	  and	  undifferentiated	  states	  [98,	  99].
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Chapter	  2 Rationale	  and	  objectives	  The	  purpose	  of	  this	  project	  was	  to	  determine	  if	  medulloblastoma	  cell	  lines	  could	  be	  induced	  to	  differentiate	  into	  cells	  that	  provide	  an	  environment	  suitable	  for	  investigation	  of	  HSV	  latency	  and	  reactivation.	  To	  this	  end,	  the	  first	  aim	  was	  to	  characterize	  differentiation	  of	  medulloblastoma	  lines	  as	  neuronal	  or	  glial.	  The	  second	  aim	  was	  to	  determine	  if	  latent	  HSV	  infection	  of	  these	  differentiated	  cells	  could	  be	  achieved,	  and	  what	  parameters	  were	  necessary	  for	  this	  to	  occur.	  Finally,	  the	  process	  of	  HSV	  reactivation	  was	  examined	  within	  the	  differentiated	  medulloblastoma	  cell	  lines.
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Chapter	  3 Materials	  and	  Methods	  
3.1 Cell	  culture	  	   Three	  human	  medulloblastoma	  cell	  lines	  were	  utilized	  in	  this	  study:	  ONS-­‐76	  and	  UW228,	  obtained	  from	  Dr.	  Michael	  Taylor	  (The	  Hospital	  for	  Sick	  Children,	  University	  of	  Toronto),	  and	  Med283,	  obtained	  from	  the	  American	  Type	  Culture	  Collection.	  To	  support	  analysis	  of	  these	  cell	  lines,	  the	  Vero	  line	  of	  African	  Green	  Monkey	  kidney	  cells,	  U2OS	  line	  of	  human	  osteosarcoma	  cells,	  PC-­‐12	  line	  of	  rat	  pheochromocytoma	  cells,	  and	  MRC-­‐5	  line	  of	  human	  fetal	  fibroblasts	  were	  also	  used.	  Immunofluorescent	  staining	  experiments	  additionally	  utilized	  cultures	  of	  neurons	  harvested	  from	  dorsal	  root	  ganglia	  of	  adult	  male	  Wistar	  rats,	  prepared	  by	  Zhengxin	  Ying	  (Cameco	  MS	  Neuroscience	  Research	  Center,	  University	  of	  Saskatchewan).	  	  All	  cell	  cultures	  were	  maintained	  in	  a	  37°C,	  5%	  CO2	  incubator	  (culturing	  conditions)	  throughout	  the	  course	  of	  experimentation	  unless	  otherwise	  indicated.	  Complete	  media	  formulations	  used	  for	  each	  cell	  line	  are	  listed	  in	  Table	  3.1,	  and	  all	  media	  used	  in	  the	  course	  of	  study	  additionally	  contained	  1%	  penicillin	  and	  streptomycin	  (Life	  Technologies)	  to	  prevent	  bacterial	  growth.	  When	  confluent,	  adherent	  cell	  lines	  were	  reseeded	  by	  incubating	  with	  trypsin-­‐EDTA	  (Life	  Technologies)	  followed	  by	  dilution	  in	  appropriate	  media	  and	  transfer	  to	  a	  new	  75cm2	  culture	  flask.	  Non-­‐adherent	  cell	  lines	  were	  diluted	  in	  appropriate	  media	  and	  transferred	  to	  a	  new	  culture	  flask	  without	  trypsin-­‐EDTA	  incubation.	  	  
3.2 Virus	  The	  herpes	  simplex	  virus	  type	  1	  strain	  KOS	  was	  utilized	  as	  the	  wild	  type	  strain	  in	  all	  experiments.	  The	  KOS-­‐derived	  HSV	  mutant	  V422	  lacks	  the	  C-­‐terminal	  activation	  domain	  of	  VP16	  [100]	  and	  was	  obtained	  from	  Dr.	  James	  Smiley	  (University	  of	  Alberta).	  The	  HSV	  n212	  mutant,	  utilized	  in	  Gardella	  gel	  experiments,	  is	  similarly	  derived	  from	  strain	  KOS	  and	  lacks	  ICP0	  activity	  by	  virtue	  of	  a	  nonsense	  mutation	  inserted	  into	  both	  copies	  of	  the	  gene	  [101].	  The	  n212	  mutant	  was	  also	  obtained	  from	  Dr.	  James	  Smiley	  (University	  of	  Alberta).	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Table	  3.1	  Cell	  lines	  and	  complete	  growth	  media	  used	  Cell	  line	   Complete	  media	  composition	  Med283	   MEM,	  10%	  FBS,	  1mM	  Na	  pyruvate,	  non-­‐essential	  amino	  acids	  MRC-­‐5	   D-­‐MEM,	  10%	  FBS	  ONS-­‐76	   D-­‐MEM,	  10%	  FBS	  PC-­‐12	   RPMI	  1640,	  10%	  inactivated	  horse	  serum,	  5%	  FBS,	  2mM	  L-­‐glutamine	  U2OS	   D-­‐MEM,	  10%	  FBS	  UW228	   D-­‐MEM/F12	  mix,	  10%	  FBS	  Vero	   D-­‐MEM,	  10%	  NBCS	  MEM;	  minimal	  essential	  media,	  FBS;	  fetal	  bovine	  serum,	  D-­‐MEM;	  Dulbecco’s	  modified	  Eagle	  medium,	  RPMI;	  Roswell	  Park	  Memorial	  Institute	  medium,	  F12;	  Ham’s	  F12	  nutrient	  mixture,	  NBCS;	  newborn	  calf	  serum.	  Low	  serum	  media	  contains	  the	  same	  composition	  with	  serum	  content	  reduced	  to	  1%.	  All	  listed	  reagents	  were	  obtained	  through	  Life	  Technologies.	  	   Infection	  by	  all	  HSV	  strains	  was	  performed	  as	  follows.	  Virus	  stock	  was	  diluted	  to	  the	  indicated	  multiplicity	  of	  infection	  (MOI,	  plaque	  forming	  units	  per	  cell)	  in	  D-­‐MEM	  for	  a	  final	  volume	  of	  250µl	  per	  individual	  9.5cm2	  well	  of	  a	  6-­‐well	  plate.	  MOI	  was	  calculated	  using	  an	  estimate	  of	  1x106	  cells	  per	  9.5cm2	  well	  if	  cells	  were	  confluent,	  and	  by	  averaging	  cell	  density	  calculated	  from	  3	  independent	  microscope	  fields	  if	  cells	  were	  not	  confluent.	  Cell	  cultures	  were	  prepared	  for	  inoculation	  by	  removing	  media	  and	  rinsing	  with	  sterile	  phosphate	  buffered	  saline	  (PBS).	  Inoculum	  was	  then	  added	  and	  cultures	  incubated	  in	  culturing	  conditions	  for	  1	  hour	  with	  gentle	  rocking	  every	  10	  minutes.	  After	  incubation,	  the	  inoculum	  was	  removed	  and	  wells	  were	  washed	  with	  2ml	  of	  pH	  3.0	  glycine-­‐saline	  buffer	  followed	  immediately	  by	  two	  PBS	  washes.	  The	  appropriate	  culturing	  media	  (Table	  3.1)	  was	  then	  added	  and	  the	  plate	  returned	  to	  the	  incubator.	  When	  necessary,	  acyclovir	  (ACV,	  Sigma)	  was	  added	  to	  cultures	  at	  a	  concentration	  of	  100µM	  24	  hours	  before	  infection.	  HSV	  KOS	  stocks	  were	  created	  previously	  in	  this	  laboratory	  by	  amplifying	  the	  virus	  and	  determining	  stock	  titer	  on	  Vero	  cells.	  HSV	  V422	  and	  n212	  possess	  deletions	  that	  significantly	  impair	  viral	  replication	  in	  many	  cell	  lines,	  and	  stocks	  are	  best	  grown	  in	  U2OS	  cells,	  which	  complement	  these	  defects	  and	  permit	  high	  titers	  to	  be	  obtained	  [87,	  102].	  Stocks	  of	  the	  two	  mutant	  viruses	  were	  generated	  by	  infecting	  culture	  flasks	  of	  confluent	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U2OS	  cells	  at	  an	  MOI	  of	  0.05	  (with	  input	  virus	  diluted	  to	  6ml/flask	  to	  accommodate	  the	  large	  surface	  area),	  followed	  by	  incubation	  in	  complete	  media	  containing	  3mM	  hexamethylene	  bis(acetamide)	  (HMBA,	  Sigma)	  to	  aid	  plaquing	  efficiency.	  Virus	  was	  harvested	  when	  the	  majority	  of	  infected	  cells	  displayed	  cytopathic	  effects	  (CPE),	  characterized	  as	  cells	  becoming	  large,	  rounded,	  and	  refractile.	  Purification	  of	  viral	  stocks	  consisted	  of	  pelleting	  infected	  cultures,	  lysing	  cells	  through	  a	  series	  of	  three	  freeze-­‐thaw	  cycles,	  and	  centrifugation	  to	  clear	  cellular	  debris.	  Adenovirus	  vectors	  were	  constructed	  previously	  in	  this	  laboratory	  to	  express	  the	  human	  CREB3/Luman	  protein	  (Luman),	  or	  Escherichia	  coli	  β-­‐galactosidase	  (LacZ).	  To	  infect	  cell	  cultures,	  growth	  media	  was	  removed	  and	  replaced	  with	  the	  appropriate	  adenovirus	  vector	  diluted	  to	  an	  MOI	  of	  100	  in	  a	  final	  volume	  of	  250µl	  per	  9.5cm2	  well	  in	  OptiMEM	  (Life	  Technologies).	  The	  virus	  was	  incubated	  with	  the	  cells	  for	  1	  hour	  in	  culturing	  conditions	  with	  rocking	  every	  10	  minutes,	  following	  which	  the	  inoculum	  was	  replaced	  with	  2ml	  of	  media	  appropriate	  for	  the	  infected	  cells	  (Table	  3.1).	  
3.3 Plaque	  Assay	  Plaque	  assays	  were	  utilized	  to	  determine	  the	  titer	  of	  infectious	  virus	  present	  in	  a	  given	  sample.	  For	  analysis	  of	  all	  HSV	  strains,	  U2OS	  cells	  were	  plated	  at	  a	  density	  of	  1x105	  cells	  per	  well	  in	  24-­‐well	  plates	  24	  to	  48	  hours	  prior	  to	  infection.	  Samples	  were	  subjected	  to	  three	  freeze-­‐thaw	  cycles	  followed	  by	  centrifugation	  for	  10	  minutes	  at	  100g,	  and	  the	  resulting	  supernatant	  was	  used	  to	  prepare	  serial	  dilutions	  in	  D-­‐MEM.	  Tenfold	  dilutions	  from	  1x10-­‐2	  to	  1x10-­‐7	  were	  prepared	  and	  tested	  in	  the	  plaque	  assay.	  Media	  was	  removed	  from	  the	  U2OS	  cells	  and	  100µl	  of	  diluted	  sample	  was	  added	  to	  each	  well,	  followed	  by	  1	  hour	  of	  incubation	  with	  rocking	  every	  10	  minutes.	  At	  1	  hour	  post	  infection,	  inoculum	  was	  removed	  and	  D-­‐MEM	  containing	  1%	  pooled	  human	  serum	  (Fisher	  Scientific)	  and	  3mM	  HMBA	  was	  added.	  When	  plaques	  developed	  to	  a	  visually	  apparent	  size,	  the	  U2OS	  cells	  were	  fixed	  in	  ice-­‐cold	  methanol	  for	  15	  minutes,	  and	  stained	  with	  Giemsa	  stain	  (prepared	  by	  GMP	  at	  the	  Western	  College	  of	  Veterinary	  Medicine)	  to	  aid	  visualization.	  Wells	  containing	  between	  1	  and	  50	  plaques	  were	  counted	  and	  divided	  by	  the	  dilution	  factor	  to	  determine	  the	  number	  of	  plaque	  forming	  units	  (pfu)	  per	  ml.	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3.4 WST	  assay	  	   The	  WST-­‐1	  assay	  (Roche	  Applied	  Science)	  was	  utilized	  to	  determine	  proliferation	  of	  cells	  in	  culture.	  96-­‐well	  plates	  were	  seeded	  with	  100µl	  of	  1x105	  cells/ml	  for	  a	  final	  concentration	  of	  1x104	  cells/well.	  Media	  was	  replaced	  every	  3	  days	  to	  support	  long-­‐term	  cell	  growth.	  To	  perform	  the	  assay,	  10µl	  of	  WST-­‐1	  reagent	  was	  added	  to	  each	  well	  and	  the	  plate	  incubated	  in	  culturing	  conditions	  for	  45	  minutes.	  After	  incubation,	  absorbance	  at	  450	  nanometers	  was	  read	  in	  a	  VMax	  Kinetic	  ELISA	  Microplate	  Reader	  (Molecular	  Devices).	  The	  WST-­‐1	  reagent	  is	  a	  tetrazolium	  salt	  cleaved	  to	  produce	  a	  formazan	  dye	  through	  a	  mechanism	  dependent	  on	  active	  cellular	  metabolism,	  therefore	  the	  quantity	  of	  dye	  produced	  directly	  correlates	  to	  the	  number	  of	  metabolically	  active	  cells	  in	  culture.	  
3.5 Indirect	  immunofluorescent	  staining	  	   Indirect	  immunofluorescent	  staining	  (IF)	  was	  utilized	  to	  determine	  the	  presence	  of	  proteins	  in	  a	  cell,	  as	  assessed	  by	  fluorescent	  emission	  from	  specific	  bound	  antibody	  complexes.	  To	  promote	  adherence	  of	  differentiating	  cells,	  coverslips	  were	  soaked	  in	  concentrated	  HCl,	  washed	  thoroughly	  with	  ultrapure	  water,	  soaked	  in	  ethanol,	  and	  finally	  coated	  with	  a	  solution	  of	  40µg/ml	  poly-­‐D-­‐lysine	  (Sigma)	  and	  4µg/ml	  laminin	  (BD	  Biosciences).	  Cells	  were	  seeded	  into	  6-­‐well	  plates	  containing	  prepared	  coverslips	  at	  an	  initial	  density	  of	  2x104	  cells	  per	  well	  and	  grown	  as	  indicated	  in	  experiment	  details.	  PC-­‐12	  cells	  were	  differentiated	  through	  incubation	  with	  100ng/ml	  NGF	  (Cedarlane)	  for	  4	  days.	  Cells	  were	  prepared	  for	  staining	  by	  fixation	  in	  ice-­‐cold	  methanol	  for	  20	  minutes	  at	  -­‐20°C.	  Fixed	  cells	  were	  stained	  according	  to	  the	  standard	  protocols	  of	  the	  Misra	  laboratory	  (M	  protocol)	  or	  Verge	  laboratory	  (VV	  protocol),	  as	  per	  the	  location	  of	  the	  staining.	  The	  M	  protocol	  was	  utilized	  for	  ONS-­‐76,	  UW228,	  and	  PC-­‐12	  cells,	  and	  was	  performed	  as	  follows:	  fixed	  cells	  were	  incubated	  in	  2ml/well	  of	  blocking	  solution,	  comprised	  of	  10%	  NBCS	  and	  0.1%	  Tween	  20	  (USB	  Products)	  in	  PBS,	  for	  20	  minutes	  at	  room	  temperature.	  Blocking	  solution	  was	  removed	  and	  30µl	  of	  primary	  antibody,	  diluted	  by	  the	  factor	  indicated	  in	  Table	  3.2,	  added	  directly	  to	  each	  coverslip.	  Plates	  with	  primary	  antibody	  were	  incubated	  for	  30	  minutes	  in	  a	  moist	  chamber	  to	  prevent	  drying.	  Following	  incubation	  wells	  were	  washed	  4	  times	  with	  PBS	  and	  incubated	  for	  5	  minutes	  in	  blocking	  solution.	  Fluor-­‐conjugated	  secondary	  antibody	  was	  diluted	  by	  the	  factor	  indicated	  in	  Table	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3.2,	  and	  30µl	  added	  to	  each	  coverslip.	  Plates	  were	  then	  incubated	  for	  30	  minutes	  in	  a	  dark	  moist	  chamber,	  following	  which	  wells	  were	  washed	  an	  additional	  4	  times	  with	  PBS	  to	  complete	  the	  staining	  procedure.	  	  	  
Table	  3.2	  Reagents	  used	  in	  IF	  staining	  Antibody	   Source	   Dilution	  Primary	  antibodies	  
β-­‐tubulin	  III	   Millipore,	  MAB1637	   1:50	  Brn3A	   Sigma	  B9684	   1:100	  GFAP	   DAKO,	  Z0334	   1:100	  NF	  (M	  protocol)	  	   Sigma	  N5264	   1:50	  NF	  (VV	  protocol)	   Abcam,	  ab8135	   1:100	  NeuN	   Abcam,	  ab104225	   1:50	  TrkA	   Biovision,	  3194-­‐100	   1:50	  Secondary	  antibodies	  Alexa	  488	   Molecular	  probes,	  A-­‐11001	   1:500	  Alexa	  546	   Molecular	  probes,	  A-­‐11010	   1:500	  Nuclear	  stains	  PI	   Molecular	  probes,	  P1304MP	   1µg/ml	  DAPI	   -­‐-­‐	   In	  mounting	  media	  Brn3A;	  brain-­‐specific	  homeobox/POU	  domain	  protein	  3A,	  GFAP;	  glial	  fibrillary	  acidic	  protein,	  NF;	  neurofilament,	  NeuN;	  neuronal	  nuclear	  antigen	  (Fox-­‐3),	  TrkA;	  neurotrophic	  tyrosine	  kinase	  receptor	  type	  1,	  PI;	  propidium	  iodide,	  DAPI;	  4’6-­‐diamidino-­‐2-­‐phenylindole.	  Secondary	  antibodies	  are	  fluor-­‐conjugated	  anti-­‐mouse	  or	  anti-­‐rabbit	  immunoglobulin.	  Antibodies	  were	  diluted	  in	  blocking	  solution	  for	  the	  M	  protocol	  and	  in	  PBST	  for	  the	  VV	  protocol.	  Nuclear	  stains	  were	  diluted	  in	  ultrapure	  water.	  	   	  	  	  	  
	   22	  
The	  VV	  protocol	  was	  utilized	  for	  UW228	  cells	  and	  rat	  neuron	  cultures	  and	  was	  performed	  as	  follows:	  blocking	  solution,	  comprised	  of	  2%	  horse	  serum,	  2%	  goat	  serum,	  and	  0.5%	  bovine	  serum	  albumin	  in	  phosphate	  buffered	  saline	  +	  0.1%	  Triton-­‐X	  (PBST),	  was	  added	  to	  fixed	  cells	  and	  incubated	  for	  30	  minutes.	  This	  was	  then	  removed	  and	  100µl	  of	  diluted	  primary	  antibody	  (Table	  3.2)	  added	  to	  each	  coverslip.	  Primary	  antibody	  incubation	  took	  place	  overnight	  at	  4°C,	  and	  unbound	  antibody	  was	  washed	  off	  the	  following	  day	  with	  3	  PBST	  washes	  of	  5	  minutes	  each.	  100µl	  of	  secondary	  antibody	  dilution	  was	  added	  to	  the	  coverslips,	  and	  plates	  incubated	  for	  1	  hour	  in	  the	  dark.	  The	  coverslips	  were	  again	  washed	  three	  times	  with	  PBST	  for	  5	  minutes	  to	  complete	  the	  staining	  procedure.	  Staining	  using	  the	  VV	  protocol	  took	  place	  at	  the	  Cameco	  MS	  Neuroscience	  Research	  Center,	  with	  all	  reagents	  excepting	  antibodies	  graciously	  provided	  by	  Dr.	  Valerie	  Verge.	  For	  both	  protocols,	  slides	  were	  prepared	  for	  visualization	  by	  inverting	  coverslips	  onto	  a	  drop	  of	  mounting	  media	  (50%	  PBS/50%	  glycerol,	  commercial	  preparation	  containing	  DAPI	  used	  for	  the	  VV	  protocol)	  and	  sealing	  with	  clear	  nail	  polish.	  Cells	  were	  examined	  by	  fluorescent	  microscopy	  using	  an	  Olympus	  BX51	  microscope,	  and	  images	  captured	  and	  edited	  using	  DP	  Controller	  (Olympus)	  and	  Northern	  Eclipse	  software	  (EMPIX	  Imaging	  Inc.).	  	  
3.6 RNA	  purification	  and	  qRT-­‐PCR	  To	  determine	  and	  quantify	  transcription	  from	  specific	  cellular	  and	  viral	  genes,	  quantitative	  real-­‐time	  polymerase	  chain	  reaction	  (qRT-­‐PCR)	  was	  performed	  on	  RNA	  extracted	  from	  culture	  samples.	  For	  isolation	  of	  total	  RNA	  from	  samples,	  the	  RNeasy	  Plus	  Mini	  kit	  (Qiagen)	  and	  included	  procedure	  for	  mRNA	  extraction	  were	  used.	  Purified	  RNA	  was	  quantified	  on	  a	  Nanodrop	  2000c	  spectrophotometer	  (Thermo	  Scientific)	  and	  a	  standardized	  amount	  of	  RNA	  (to	  a	  maximum	  of	  1µg)	  was	  used	  as	  template	  for	  cDNA	  synthesis.	  The	  Quantitect	  Reverse	  Transcription	  kit	  (Qiagen)	  and	  a	  PTC-­‐200	  Peltier	  Thermal	  Cycler	  (MJ	  Research)	  were	  utilized	  to	  generate	  cDNA	  for	  use	  in	  qRT-­‐PCR	  according	  to	  the	  protocol	  specified	  by	  the	  manufacturer.	  PCR	  reactions	  were	  set	  up	  in	  duplicate	  using	  the	  Brilliant	  II	  SYBR	  Green	  qPCR	  Master	  Mix	  kit	  (Agilent	  Technologies),	  and	  the	  abundance	  of	  specific	  gene	  transcripts	  quantified	  by	  qRT-­‐PCR	  in	  a	  Stratagene	  Mx3005P	  thermal	  cycler.	  The	  thermal	  program	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consisted	  of	  heating	  to	  95°C	  for	  10	  minutes,	  followed	  by	  40	  cycles	  of	  95°C	  for	  30	  seconds,	  55°C	  for	  1	  minute,	  and	  72°C	  for	  1	  minute,	  and	  finally	  one	  cycle	  of	  95°C	  for	  1	  minute,	  55°C	  for	  30	  seconds,	  and	  95°C	  for	  30	  seconds.	  Ct	  values	  generated	  through	  this	  program	  were	  converted	  to	  absolute	  values	  using	  standard	  curves	  correlating	  Ct	  and	  the	  number	  of	  gene	  equivalents	  present.	  Standard	  curves	  were	  produced	  by	  performing	  PCR	  on	  serial	  dilutions	  of	  purified	  HSV	  or	  HeLa	  cell	  DNA	  and	  generating	  the	  equation	  of	  the	  line	  of	  best	  fit.	  PCR	  primer	  targets	  and	  sequences	  are	  listed	  in	  Table	  3.3.	  	  
Table	  3.3	  Primers	  used	  in	  qRT-­PCR	  reactions	  Primer	  target	   Source	   Sequence	  F	  –	  TGCCTCCTGCACCACCAACTGC	  GAPDH	   Valderrama	  et	  al.	  [103]	   R	  –	  GGGCCATCCACAGTCTTCTGGG	  F	  –	  CTCCTCTGCCTCTTCCTCCT	  HSV	  ICP0	   In-­‐house	   R	  –	  TTGTTCACGTAAGGCGACAG	  	  F	  –	  GCATAGAGAGCCAGGCACAAAA	  	  HSV	  LAT	   Du	  et	  al.	  [62]	   R	  –	  ACGTACTCCAAGAAGGCATGTG	  	  F	  –	  CCATCAACACGCGTCTGCGTT	  	  HSV	  TK	   In-­‐house	   R	  –	  CCAGTAAGTCATCGGCTCGG	  	  F	  –	  CTTCTGCGAGACGAGCTTTT	  	  HSV	  VP5	   In-­‐house	   R	  –	  CCACTTTCAGGAAGGACTGC	  F	  –	  GGACGAGCTCCACTTAGACG	  	  HSV	  VP16	  (for	  KOS)	   In-­‐house	   R	  –	  AGGGCATCGGTAAACATCTG	  F	  –	  GCAGGCCCTCGATGGTAGAC	  HSV	  VP16	  (for	  V422)	   K.	  Schroeder	   R	  –	  CCGCGCCTCTGGGTACTTTA	  F	  –	  CCAAGTGCAGTCCAGGTTATCG	  HVEM	   K.	  Schroeder	   R	  –	  TTGCTTAGGCCATTGAGGTGG	  F	  –	  ACCAACCCCATCGGTACAC	  Nectin-­‐1	   Vetter	  et	  al.	  [104]	   R	  –	  GGGGTGTAGGGGAATTCTGT	  F	  –	  CCGGGATCCATGAGGCATAGCCTG	  ZF	   In-­‐house	   R	  -­‐	  CCGCTCGAGAGAGCAGATTACTTGA	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3.7 DNA	  purification	  and	  analysis	  To	  determine	  the	  number	  of	  viral	  and	  cellular	  genome	  copies	  present	  in	  a	  sample,	  total	  DNA	  was	  purified	  and	  assessed	  by	  qRT-­‐PCR.	  Isolation	  of	  total	  DNA	  from	  infected	  cultures	  was	  performed	  using	  the	  DNeasy	  Blood	  and	  Tissue	  kit	  (Qiagen)	  and	  included	  procedure	  for	  extraction	  from	  cultured	  cells.	  Purified	  DNA	  from	  this	  procedure	  was	  quantified	  on	  a	  Nanodrop	  spectrophotometer.	  In	  each	  sample	  the	  viral	  gene	  target	  VP16	  and	  the	  cellular	  gene	  target	  ZF	  (primer	  sequences	  in	  Table	  3.3)	  were	  quantified	  by	  qRT-­‐PCR	  in	  a	  Stratagene	  Mx3005P	  thermal	  cycler,	  with	  reactions	  set	  up	  using	  the	  Brilliant	  II	  SYBR	  Green	  qPCR	  Master	  Mix	  kit	  (Agilent	  Technologies).	  Thermal	  cycling	  of	  PCR	  reactions	  followed	  the	  same	  program	  as	  detailed	  for	  qRT-­‐PCR	  analysis	  of	  cDNA	  (Section	  3.6).	  Ct	  values	  were	  converted	  to	  absolute	  values	  using	  standard	  curves	  specific	  to	  each	  primer	  set,	  and	  the	  number	  of	  viral	  targets	  was	  divided	  by	  the	  detected	  cellular	  targets	  to	  provide	  the	  number	  of	  viral	  genome	  copies	  present	  per	  cell.	  This	  calculation	  controlled	  for	  variation	  in	  the	  total	  number	  of	  cells	  present	  in	  each	  well.	  
3.8 Gardella	  gels	  	   The	  Gardella	  gel	  protocol	  has	  been	  previously	  described	  for	  use	  in	  detecting	  latent	  herpesviruses	  [105,	  106]	  and	  was	  adapted	  for	  use	  with	  infected	  medulloblastoma	  cell	  lines.	  To	  create	  the	  resolving	  portion	  of	  the	  gel,	  225ml	  of	  molten	  0.75%	  low	  melting	  point	  agarose	  (Life	  Technologies)	  in	  0.5x	  tris	  borate	  EDTA	  buffer	  (TBE)	  with	  20µl	  of	  SYBR	  Safe	  DNA	  gel	  stain	  (Life	  Technologies)	  was	  first	  prepared	  and	  poured	  into	  a	  20.25cm	  x	  15cm	  casting	  tray	  with	  a	  15-­‐well	  comb	  set	  4.5cm	  from	  the	  top	  of	  the	  gel.	  Once	  this	  gel	  had	  polymerized,	  the	  comb	  was	  removed	  and	  the	  top	  4.5cm	  excised	  and	  discarded.	  To	  create	  the	  lysis	  portion	  of	  the	  gel,	  50ml	  of	  molten	  0.8%	  agarose	  (Life	  Technologies)	  was	  prepared	  and	  allowed	  to	  cool	  before	  addition	  of	  2%	  SDS	  (prepared	  by	  GMP)	  and	  1mg/ml	  self-­‐digested	  pronase	  (Sigma).	  The	  comb	  was	  replaced	  into	  the	  casting	  tray	  and	  the	  molten	  lysis	  gel	  poured	  to	  replace	  the	  excised	  portion	  of	  the	  resolving	  gel.	  	   Cells	  were	  seeded	  in	  a	  staggered	  fashion	  so	  the	  appropriate	  duration	  of	  viral	  infection	  was	  reached	  on	  the	  day	  the	  Gardella	  gel	  was	  loaded.	  As	  the	  lysis	  gel	  was	  polymerizing	  approximately	  5x105	  cells	  for	  each	  indicated	  time	  point	  were	  rinsed	  with	  PBS	  and	  scraped	  into	  15ml	  Falcon	  tubes,	  followed	  by	  4°C	  centrifugation	  at	  200g	  for	  10	  minutes.	  
	   25	  
The	  supernatant	  was	  discarded	  and	  cells	  gently	  resuspended	  in	  25µl	  of	  Gardella	  sample	  buffer	  (20%	  Ficoll	  (Pharmacia),	  0.01%	  bromophenol	  blue	  (EMD)	  in	  TBE)	  and	  kept	  on	  ice	  until	  gel	  loading.	  	   At	  4°C	  the	  polymerized	  gel	  was	  immersed	  in	  0.5x	  TBE	  and	  loaded	  with	  25µl	  of	  cell	  sample	  per	  well.	  To	  lyse	  the	  loaded	  cells	  the	  gel	  was	  run	  first	  at	  40V	  for	  2	  hours,	  followed	  by	  resolving	  DNA	  from	  the	  lysed	  cells	  by	  running	  the	  gel	  for	  16	  hours	  at	  140V.	  After	  running,	  each	  lane	  was	  cut	  into	  0.5cm	  slices	  using	  a	  separate	  scalpel	  blade	  for	  each	  region	  within	  each	  sample	  so	  as	  to	  avoid	  cross-­‐contamination.	  Gel	  slices	  were	  collected	  in	  1.5ml	  microcentrifuge	  tubes	  and	  stored	  at	  4°C.	  	   To	  determine	  if	  viral	  DNA	  was	  present,	  tubes	  containing	  gel	  slices	  were	  heated	  to	  65°C	  for	  15-­‐20	  minutes	  to	  melt	  the	  agarose,	  and	  5µl	  from	  the	  resulting	  liquid	  was	  added	  to	  PCR	  reactions	  as	  template.	  PCR	  reactions	  were	  prepared	  using	  the	  TopTaq	  DNA	  Polymerase	  kit	  (Qiagen).	  For	  each	  50µl	  reaction,	  5µl	  of	  10x	  PCR	  buffer,	  0.25µl	  of	  TopTaq	  (both	  included	  in	  the	  kit),	  2µl	  of	  both	  5µM	  VP5	  primers,	  1µl	  of	  dNTP	  mix	  (Life	  Technologies),	  34.75µl	  ultra-­‐pure	  water,	  and	  gel	  template	  were	  combined	  and	  run	  in	  a	  PTC-­‐200	  Peltier	  Thermal	  Cycler	  (MJ	  Research).	  The	  amplification	  program	  utilized	  was	  94°C	  for	  3	  minutes,	  followed	  by	  30	  cycles	  of	  94°C	  for	  30s,	  55°C	  for	  45s,	  72°C	  for	  1	  minute,	  and	  a	  final	  extension	  time	  of	  10	  minutes	  at	  72°C.	  PCR	  products	  were	  run	  on	  an	  0.8%	  agarose	  gel	  containing	  1mg/ml	  ethidium	  bromide	  and	  visualized	  on	  an	  Alpha	  Innotech	  Alpha	  Imager.	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Chapter	  4 Results	  
4.1 Generating	  neuronally-­‐differentiated	  medulloblastoma	  cell	  cultures	  	   The	  first	  aim	  of	  this	  project	  was	  to	  develop	  human	  medulloblastoma	  tumour	  cell	  lines	  into	  neuronally-­‐differentiated	  cultures.	  This	  was	  accomplished	  by	  screening	  a	  variety	  of	  known	  differentiation	  agents	  for	  the	  ability	  to	  stimulate	  a	  change	  in	  the	  medulloblastoma	  cell	  lines.	  Differentiated	  cells	  identified	  through	  the	  screening	  process	  were	  then	  examined	  to	  determine	  cell	  character.	  
4.1.1 Screen	  of	  medulloblastoma	  cell	  response	  to	  differentiation	  stimuli	  	   Medulloblastoma	  cell	  lines	  are	  known	  to	  differentiate	  along	  a	  neuronal	  pathway	  in	  response	  to	  a	  variety	  of	  chemical	  agents	  [95,	  96,	  107,	  108].	  A	  screen	  of	  these	  agents	  was	  performed	  on	  the	  Med283,	  ONS-­‐76,	  and	  UW228	  medulloblastoma	  cell	  lines	  (Table	  4.1)	  to	  determine	  if	  a	  population	  of	  neuronally	  differentiated	  cells	  could	  be	  generated	  that	  would	  be	  suitable	  for	  use	  in	  HSV	  latency	  studies.	  Dibutyryl	  cyclic	  adenosine	  monophosphate	  (DBcAMP)	  and	  resveratrol	  are	  compounds	  that	  have	  been	  described	  to	  stimulate	  neuronal	  differentiation	  in	  medulloblastoma	  cell	  lines	  [95,	  107].	  These	  agents	  were	  therefore	  screened	  to	  characterize	  their	  ability	  to	  induce	  differentiation	  in	  Med283,	  ONS-­‐76	  and	  UW228	  cells.	  Because	  of	  its	  role	  in	  maintenance	  of	  HSV	  latency,	  NGF	  was	  included	  in	  the	  screen	  although	  NGF	  signaling	  has	  been	  linked	  to	  apoptotic	  pathway	  induction	  in	  medulloblastomas	  [109].	  Aphidicolin	  has	  classically	  been	  used	  in	  neuronal	  cell	  culture	  to	  control	  growth	  of	  mitotic	  cells	  and	  was	  also	  utilized	  as	  a	  screening	  chemical.	  The	  screen	  for	  successful	  differentiation	  used	  three	  criteria:	  i) That	  the	  cells	  developed	  a	  neuronal	  morphology,	  with	  features	  such	  as	  the	  outgrowth	  of	  neurite-­‐like	  processes	  ii) That	  the	  number	  of	  cells	  in	  culture	  became	  stable,	  a	  phenomenon	  associated	  with	  cells	  becoming	  post-­‐mitotic	  iii) That	  differentiation	  be	  achieved	  within	  15	  days	  of	  treatment	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Table	  4.1	  Characteristics	  of	  medulloblastoma	  cell	  lines	  	   ONS-­‐76	   UW228	   Med283	  Origin	   2	  year	  old	  female	   9	  year	  old	  female	   6	  year	  old	  male	  Site	   Cerebellum	   Posterior	  fossa	   Peritoneum	  &	  ascites	  Derived	   1987	   1995	   1985	  IHC	   Neurofilament,	  enolase,	  GFAP,	  S-­‐100	  protein	  	  
Neurofilament,	  synaptophysin,	  GFAP	   Neurofilament,	  enolase,	  GFAP,	  S-­‐100	  protein	  Expression	   Neurofilament,	  enolase	   Neurofilament,	  synaptophysin	   Neurofilament,	  enolase	  Source	   Tamura	  et	  al.	  [110]	   Keles	  et	  al.	  [111]	   Friedman	  et	  al.	  [112]	  	   Every	  possible	  combination	  of	  DBcAMP,	  resveratrol,	  NGF	  and	  aphidicolin	  was	  used	  to	  treat	  an	  individual	  culture	  (Table	  4.2),	  with	  media	  being	  refreshed	  every	  3	  days.	  Morphology	  was	  monitored	  over	  a	  15	  day	  period,	  and	  several	  types	  were	  observed	  to	  develop	  by	  the	  end	  of	  treatment,	  as	  summarized	  in	  Figure	  4.1.	  Out	  of	  the	  total	  screened	  treatments,	  two	  cultures	  of	  ONS-­‐76	  and	  two	  of	  UW228	  cells	  satisfied	  the	  criteria	  and	  were	  put	  forth	  for	  further	  assessment.	  The	  treatments	  resulting	  in	  differentiation	  were	  DBcAMP	  and	  resveratrol	  with	  or	  without	  NGF	  for	  ONS-­‐76	  cells,	  and	  DBcAMP	  with	  or	  without	  NGF	  for	  UW228	  cells.	  Med283	  cells	  were	  not	  stimulated	  to	  differentiate	  according	  to	  screen	  criteria	  by	  any	  of	  the	  tested	  agents	  or	  combinations	  thereof.	  Table	  4.2	  lists	  the	  morphology	  developed	  by	  each	  individual	  treatment	  group	  at	  the	  end	  of	  the	  screen.	  	   Differentiation	  of	  ONS-­‐76	  cells	  in	  subsequent	  experiments	  was	  achieved	  through	  treatment	  with	  DBcAMP	  and	  resveratrol,	  and	  differentiation	  of	  UW228	  cells	  with	  DBcAMP	  and	  NGF.	  The	  differentiation	  protocol	  utilized	  was	  as	  follows:	  cells	  were	  seeded	  in	  complete	  media	  and	  allowed	  to	  recover	  for	  48	  hours	  before	  changing	  to	  low	  serum	  media	  containing	  the	  appropriate	  differentiation	  agents.	  This	  media	  was	  then	  replenished	  every	  three	  days	  for	  the	  remainder	  of	  the	  experiment,	  and	  cells	  were	  considered	  to	  be	  differentiated	  after	  12	  days	  of	  incubation	  with	  differentiation	  agents.	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Figure	  4.1	  Morphology	  of	  medulloblastoma	  cell	  lines	  treated	  with	  differentiation	  
agents.	  	  Medulloblastoma	  cell	  lines	  Med283,	  UW228	  and	  ONS-­‐76	  were	  seeded	  in	  24-­‐well	  plates	  at	  a	  density	  of	  5x104	  cells/well	  in	  complete	  media.	  Cells	  were	  allowed	  to	  recover	  for	  48h	  before	  media	  was	  changed	  to	  low	  serum	  media	  containing	  differentiating	  agents	  (day	  0).	  Media	  was	  replaced	  every	  three	  days,	  maintaining	  concentrations	  of	  differentiating	  agents.	  Pictures	  are	  examples	  of	  the	  distinct	  morphologies	  developed	  by	  treated	  cultures	  at	  day	  15.	  For	  the	  morphology	  developed	  by	  individual	  treatment	  groups	  see	  Table	  4.2.	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Table	  4.2	  Morphology	  of	  differentiation	  agent-­treated	  medulloblastoma	  cell	  lines	  Med283	  Treatment	   Morphology	   Treatment	   Morphology	   Treatment	   Morphology	  D	   Death	   Media	  only	   No	  change	   RN	   Death	  R	   Death	   DR	   Death	   RA	   Death	  N	   No	  change	   DN	   No	  change	   NA	   Death	  A	   Death	   DA	   Death	   RNA	   Death	  DRN	   Death	   DNA	   Death	   DRA	   Death	  ONS-­‐76	  Treatment	   Morphology	   Treatment	   Morphology	   Treatment	   Morphology	  D	   No	  change	   Media	  only	   No	  change	   RN	   Fibroblast	  R	   Fibroblast	   DR	   Neuronal	   RA	   Death	  N	   No	  change	   DN	   No	  change	   NA	   Fibroblast	  A	   Fibroblast	   DA	   No	  change	   RNA	   Death	  DRN	   Neuronal	   DNA	   No	  change	   DRA	   Death	  UW228	  Treatment	   Morphology	   Treatment	   Morphology	   Treatment	   Morphology	  D	   Neuronal	   Media	  only	   No	  change	   RN	   Death	  R	   Death	   DR	   Death	   RA	   Death	  N	   No	  change	   DN	   Neuronal	   NA	   Death	  A	   Death	   DA	   Death	   RNA	   Death	  DRN	   Death	   DNA	   Death	   DRA	   Death	  Cultures	  were	  seeded	  and	  maintained	  as	  described	  in	  Figure	  4.1.	  Final	  concentrations	  of	  DBcAMP,	  NGF,	  resveratrol,	  and	  aphidicolin	  were	  1mM,	  100ng/ml,	  10µM	  and	  4µg/ml,	  respectively.	  D;	  DBcAMP,	  R;	  resveratrol,	  N;	  NGF,	  A;	  aphidicolin.	  	  
4.1.2 Assessment	  of	  differentiated	  medulloblastoma	  cell	  proliferation	  To	  characterize	  changes	  in	  proliferation	  of	  the	  differentiating	  medulloblastoma	  cells,	  a	  WST	  assay	  was	  performed.	  The	  growth	  of	  differentiating	  cells	  was	  compared	  to	  control	  cells,	  with	  the	  only	  difference	  between	  treatment	  groups	  being	  the	  presence	  of	  differentiation	  agents.	  ONS-­‐76	  cell	  cultures	  treated	  with	  DBcAMP	  and	  resveratrol	  do	  not	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proliferate	  to	  the	  same	  magnitude	  as	  untreated	  controls	  and	  instead	  become	  relatively	  stable	  in	  number,	  a	  phenomenon	  visually	  evident	  by	  15	  days	  of	  differentiation	  (Figure	  4.1).	  Cessation	  of	  growth	  in	  differentiating	  ONS-­‐76	  cultures	  was	  confirmed	  by	  the	  WST	  assay,	  where	  increases	  in	  control	  cell	  numbers	  exceeded	  that	  of	  treated	  cells	  (Figure	  4.2).	  UW228	  cells	  also	  appear	  to	  exhibit	  cessation	  of	  growth	  when	  treated	  with	  differentiating	  agents	  (Figure	  4.1),	  and	  this	  was	  confirmed	  by	  WST	  assay	  results	  showing	  relatively	  stable	  numbers	  of	  differentiating	  cells	  in	  culture	  (Figure	  4.3).	  As	  the	  WST	  assay	  correlates	  cellular	  metabolic	  activity	  to	  cell	  number,	  refreshing	  growth	  media	  may	  have	  amplified	  the	  oscillations	  observed	  in	  cell	  proliferation	  in	  these	  results.	  	  
	  
Figure	  4.2	  Proliferation	  of	  differentiating	  ONS-­76	  cells.	  Proliferation	  of	  differentiating	  and	  control	  ONS-­‐76	  cells	  as	  assessed	  by	  a	  WST	  assay.	  Cells	  were	  seeded	  into	  12	  96-­‐well	  plates	  at	  a	  density	  of	  1x104	  cells/well	  (day	  0)	  and	  allowed	  to	  recover	  for	  24h	  before	  changing	  media	  to	  low	  serum	  with	  or	  without	  differentiating	  agents.	  At	  the	  indicated	  day,	  the	  WST	  assay	  was	  performed	  on	  control	  and	  differentiating	  wells	  in	  an	  individual	  plate	  as	  detailed	  in	  Methods.	  Results	  are	  an	  average	  of	  4	  replicates.	  Media	  was	  refreshed	  in	  all	  plates	  on	  days	  2,	  5,	  and	  8	  (arrowheads).	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Figure	  4.3	  Proliferation	  of	  differentiating	  UW228	  cells	  Proliferation	  of	  differentiating	  and	  control	  UW228	  cells	  as	  assessed	  by	  a	  WST	  assay.	  Cells	  were	  seeded	  into	  9	  96-­‐well	  plates	  at	  a	  density	  of	  1x104	  cells/well	  (day	  0)	  and	  allowed	  to	  recover	  for	  24h	  before	  changing	  media	  to	  low	  serum	  with	  or	  without	  differentiating	  agents.	  At	  the	  indicated	  day,	  the	  WST	  assay	  was	  performed	  on	  control	  and	  differentiating	  wells	  in	  an	  individual	  plate	  as	  detailed	  in	  Methods.	  Results	  are	  an	  average	  of	  4	  replicates.	  Media	  was	  refreshed	  in	  all	  plates	  on	  days	  3,	  6,	  9,	  and	  12	  (arrowheads).	  
4.1.3 Assessment	  of	  neuronal	  protein	  expression	  in	  differentiated	  medulloblastoma	  cells	  	   Medulloblastoma	  cells	  are	  thought	  to	  derive	  from	  immature	  bipotential	  cells,	  and	  can	  be	  induced	  to	  develop	  along	  glial	  or	  neuronal	  pathways	  (see	  Section	  1.5).	  The	  expression	  of	  cell	  type-­‐specific	  marker	  proteins	  was	  investigated	  in	  differentiating	  medulloblastoma	  cells	  to	  determine	  if	  differentiation	  correlated	  with	  a	  shift	  in	  cell	  character.	  To	  this	  end,	  the	  presence	  of	  proteins	  specific	  to	  glia	  and	  neurons	  was	  defined	  in	  UW228	  and	  ONS-­‐76	  cells	  in	  both	  states	  of	  differentiation.	  Glial	  character	  was	  assessed	  by	  staining	  cultures	  for	  the	  glial	  fibrillary	  acidic	  protein	  (GFAP),	  while	  neuronal	  character	  was	  determined	  by	  staining	  for	  class	  III	  β-­‐tubulin,	  brain-­‐specific	  homeobox/POU	  domain	  protein	  3A	  (Brn3A),	  neuronal	  nuclear	  antigen/Fox-­‐3	  (NeuN),	  and	  neurofilament	  (NF)	  proteins.	  Differentiated	  PC-­‐12	  cells	  have	  been	  widely	  used	  as	  a	  cell	  culture	  model	  of	  neurons	  [113-­‐115],	  and	  staining	  for	  marker	  proteins	  was	  also	  performed	  on	  these	  cells.	  In	  addition,	  cultures	  of	  primary	  rat	  neurons	  were	  stained	  as	  a	  positive	  control	  for	  the	  neuronal	  marker	  proteins.	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   Control	  ONS-­‐76	  cells	  did	  not	  stain	  for	  the	  neuronal	  proteins	  NF	  or	  β-­‐tubulin,	  however	  did	  stain	  for	  the	  glial	  marker	  GFAP	  as	  seen	  in	  Figure	  4.4A.	  When	  differentiated	  ONS-­‐76	  cells	  were	  stained	  for	  these	  proteins	  β-­‐tubulin	  was	  detected,	  localizing	  in	  projections	  extending	  from	  the	  cell	  body	  (Figure	  4.4B).	  Expression	  of	  GFAP	  in	  differentiated	  ONS-­‐76	  cells	  was	  similar	  to	  that	  of	  the	  control	  cells,	  and	  NF	  protein	  remained	  undetectable	  post-­‐differentiation.	  Staining	  of	  differentiated	  PC-­‐12	  cells	  revealed	  the	  presence	  of	  GFAP	  with	  localization	  similar	  to	  that	  of	  the	  ONS-­‐76	  cells	  (Figure	  4.4C).	  The	  presence	  of	  β-­‐tubulin	  was	  not	  found,	  and	  while	  NF	  expression	  was	  detected	  in	  a	  few	  scattered	  cells	  it	  was	  not	  seen	  in	  the	  vast	  majority	  (Figure	  4.4C).	  These	  findings	  appear	  to	  contrast	  with	  what	  has	  been	  typically	  documented	  for	  expression	  of	  GFAP,	  NF,	  and	  β-­‐tubulin	  in	  differentiated	  PC-­‐12	  cells	  [116-­‐118].	  Despite	  the	  atypical	  staining	  of	  differentiated	  PC-­‐12	  cells	  in	  this	  experiment,	  it	  was	  concluded	  from	  the	  expression	  of	  β-­‐tubulin	  in	  differentiated	  ONS-­‐76	  cells	  that	  treatment	  with	  DBcAMP	  and	  resveratrol	  induced	  differentiation	  along	  a	  neuronal	  pathway.	  	   Staining	  performed	  on	  control	  and	  differentiated	  UW228	  cells	  using	  GFAP,	  β-­‐tubulin,	  and	  NF	  yielded	  identical	  results	  for	  both	  differentiation	  states:	  the	  presence	  of	  β-­‐tubulin	  and	  NF	  was	  not	  detected,	  and	  similar	  levels	  of	  GFAP	  staining	  were	  seen	  in	  both	  differentiated	  and	  control	  populations	  (Figure	  4.4D,	  E).	  The	  pool	  of	  neuronal	  targets	  was	  expanded	  to	  include	  Brn3A	  and	  NeuN,	  and	  cultured	  rat	  neurons	  were	  stained	  alongside	  cells	  as	  a	  positive	  control.	  UW228	  cells	  in	  both	  differentiation	  states	  exhibited	  some	  staining	  for	  NeuN,	  with	  a	  more	  nuclear	  localization	  in	  differentiated	  cells	  and	  rat	  neurons	  than	  control	  cells	  (Figure	  4.5).	  Brn3A	  staining	  in	  differentiated	  UW228	  cells	  and	  rat	  neurons	  was	  dispersed	  throughout	  the	  cytoplasm	  and	  nucleus,	  while	  in	  control	  UW228	  cells	  it	  was	  detected	  in	  a	  perinuclear	  cluster	  (Figure	  4.5).	  Finally,	  NF	  staining	  was	  performed	  using	  an	  alternate	  antibody	  to	  confirm	  previous	  staining	  results.	  As	  shown	  in	  both	  Figure	  4.4	  (D,E)	  and	  Figure	  4.5,	  NF	  was	  not	  detected	  in	  the	  UW228	  cells	  yet	  intense	  staining	  was	  seen	  in	  the	  processes	  of	  the	  rat	  neurons.	  While	  expression	  of	  the	  tested	  neuronal	  and	  glial	  proteins	  did	  not	  change	  upon	  UW228	  cell	  differentiation,	  maintained	  expression	  of	  the	  neuronal	  proteins	  Brn3A	  and	  NeuN	  indicated	  that	  although	  treatment	  did	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not	  induce	  further	  neuronal	  differentiation	  these	  cells	  exhibited	  a	  degree	  of	  neuronal	  character.	  	  
	  
Figure	  4.4	  Marker	  protein	  expression	  in	  differentiating	  medulloblastoma	  cells	  Indirect	  immunofluorescent	  staining	  was	  performed	  on	  the	  indicated	  cell	  populations	  as	  per	  the	  M	  protocol	  detailed	  in	  Methods.	  Cells	  were	  grown	  on	  coverslips	  for	  2	  days	  for	  controls	  and	  14	  days	  for	  differentiated	  medulloblastoma	  populations.	  PC-­‐12	  cells	  were	  differentiated	  for	  4	  days	  on	  coverslips	  before	  staining.	  Red	  nuclear	  staining	  is	  propidium	  iodide,	  and	  green	  staining	  results	  from	  detection	  of	  bound	  primary	  antibody.	  NF;	  neurofilament,	  β-­‐tubulin;	  class	  III	  β-­‐tubulin,	  GFAP;	  glial	  fibrillary	  acidic	  protein.	  Control	  is	  HSV	  ICP27	  antibody.	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Figure	  4.5	  Neuronal	  protein	  expression	  in	  differentiating	  UW228	  cells	  Indirect	  immunofluorescent	  staining	  was	  performed	  on	  the	  indicated	  cell	  populations	  as	  per	  the	  VV	  protocol	  detailed	  in	  Methods.	  Control	  UW228	  cells	  were	  grown	  on	  coverslips	  for	  3	  days	  and	  differentiated	  UW228	  cells	  for	  14	  days.	  Blue	  nuclear	  staining	  is	  DAPI	  and	  red	  staining	  results	  from	  detection	  of	  bound	  primary	  antibody.	  Rat	  neuron	  cultures	  were	  prepared	  on	  coverslips	  by	  Zhengxin	  Ying.	  	  
4.1.4 Expression	  of	  herpesvirus	  entry	  mediators	  	   It	  has	  been	  demonstrated	  in	  other	  neuronally-­‐differentiated	  tumour	  cells	  that	  differentiation	  coincides	  with	  changes	  in	  expression	  of	  proteins	  which	  mediate	  herpesvirus	  entry	  [76].	  Therefore,	  expression	  of	  the	  major	  HSV	  entry	  receptors	  HVEM	  and	  nectin-­‐1	  was	  assessed	  in	  control	  and	  differentiated	  UW228	  cells.	  HVEM,	  nectin-­‐1,	  and	  GAPDH	  transcription	  were	  determined	  for	  differentiated	  and	  control	  cells	  by	  qRT-­‐PCR,	  and	  fold	  change	  in	  expression	  was	  calculated.	  Results	  demonstrate	  no	  change	  in	  nectin-­‐1	  expression	  between	  differentiation	  states,	  and	  a	  slight	  decrease	  in	  HVEM	  expression	  upon	  differentiation	  (Figure	  4.6).	  Ct	  values	  obtained	  for	  the	  entry	  proteins	  ranged	  from	  cycle	  20-­‐22,	  whereas	  qRT-­‐PCR	  performed	  with	  HeLa	  genomic	  DNA	  (containing	  the	  unspliced	  target	  genes	  with	  introns)	  returned	  Ct	  values	  of	  30-­‐34.	  This	  data	  indicates	  that	  transcripts	  were	  readily	  and	  specifically	  detected	  in	  the	  UW228	  cells,	  and	  it	  was	  concluded	  that	  significant	  changes	  in	  expression	  of	  herpesvirus	  entry	  mediators	  were	  not	  observed	  upon	  differentiation.	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Figure	  4.6	  Herpesvirus	  entry	  protein	  expression	  in	  UW228	  cells	  Expression	  of	  herpesvirus	  entry	  mediators	  HVEM	  and	  nectin-­‐1	  was	  assessed	  by	  qRT-­‐PCR.	  Total	  RNA	  was	  extracted	  from	  differentiated	  and	  control	  UW228	  cells	  and	  PCR	  was	  performed	  on	  cellular	  targets	  as	  detailed	  in	  Methods.	  Expression	  of	  HVEM	  and	  nectin-­‐1	  was	  normalized	  to	  expression	  of	  the	  GAPDH	  housekeeping	  gene.	  Results	  are	  an	  average	  of	  two	  replicates	  from	  the	  same	  experiment.	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4.2 Establishing	  HSV	  latency	  in	  differentiated	  medulloblastoma	  cells	  	   The	  second	  aim	  of	  this	  project	  was	  to	  determine	  if	  latent	  HSV	  infection	  could	  be	  established	  in	  differentiated	  medulloblastoma	  cells.	  Various	  parameters	  of	  infection	  were	  explored	  in	  differentiated	  ONS-­‐76	  and	  UW228	  cells,	  such	  as	  the	  inhibition	  of	  viral	  replication	  and	  use	  of	  HSV	  mutants,	  to	  determine	  requirements	  for	  establishing	  latent	  infection.	  Infection	  was	  then	  evaluated	  to	  determine	  if	  viral	  latency,	  defined	  as	  the	  presence	  of	  viral	  DNA	  in	  the	  absence	  of	  infectious	  virus	  and	  lytic	  transcription,	  had	  been	  achieved.	  
4.2.1 Establishing	  quiescent	  HSV	  infection	  of	  differentiated	  ONS-­‐76	  cells	  	   Differentiated	  ONS-­‐76	  cells	  were	  assessed	  for	  their	  ability	  to	  host	  latent,	  or	  quiescent,	  HSV	  infection.	  To	  make	  this	  determination,	  the	  permissivity	  of	  ONS-­‐76	  cells	  to	  HSV	  replication	  post-­‐differentiation	  was	  evaluated.	  Differentiated	  cultures	  of	  ONS-­‐76	  cells	  were	  infected	  with	  the	  wild	  type	  HSV	  strain	  KOS	  at	  an	  MOI	  of	  1,	  and	  viral	  titer	  and	  cellular	  morphology	  were	  tracked	  over	  the	  following	  48	  hours	  (Figure	  4.7,	  Figure	  4.9).	  Altered	  viral	  strains	  are	  often	  required	  to	  overcome	  the	  inherent	  limitations	  of	  modeling	  HSV	  in	  cell	  culture,	  and	  as	  the	  loss	  of	  VP16	  during	  axonal	  transport	  has	  been	  reported	  to	  be	  important	  for	  latency	  establishment	  [13]	  infection	  with	  the	  HSV	  V422	  mutant	  was	  also	  explored.	  This	  mutant	  carries	  a	  truncated	  form	  of	  VP16,	  which	  lacks	  the	  activation	  domain	  that	  initiates	  entry	  into	  the	  lytic	  program	  but	  remains	  able	  to	  participate	  in	  the	  assembly	  of	  functional	  capsids	  [100].	  Plaque	  assays	  were	  performed	  to	  monitor	  changes	  in	  viral	  titer	  and	  demonstrated	  both	  KOS	  and	  V422	  to	  increase	  steadily	  over	  time	  (Figure	  4.7),	  a	  result	  consistent	  with	  replicating	  virus.	  In	  agreement	  with	  these	  results,	  infected	  cultures	  exhibited	  an	  increasing	  number	  of	  cells	  displaying	  CPE	  as	  time	  progressed	  (Figure	  4.9A).	  The	  development	  of	  CPE	  and	  increase	  in	  viral	  titer	  occurred	  more	  slowly	  for	  V422	  than	  KOS,	  which	  may	  be	  attributable	  to	  the	  impairment	  of	  this	  virus.	  It	  was	  therefore	  concluded	  that	  the	  environment	  of	  differentiated	  ONS-­‐76	  cells	  did	  not	  promote	  establishment	  of	  quiescent	  infection	  by	  HSV	  KOS	  or	  V422,	  and	  instead	  was	  permissive	  to	  productive	  replication.	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Figure	  4.7	  HSV	  replication	  in	  differentiated	  ONS-­76	  cells	  ONS-­‐76	  cells	  were	  differentiated	  in	  6-­‐well	  plates	  and	  infected	  with	  the	  HSV	  strain	  KOS	  or	  V422	  at	  an	  MOI	  of	  1.	  At	  the	  indicated	  time	  point,	  cells	  were	  scraped	  from	  the	  well	  surface	  and	  processed	  for	  determination	  of	  viral	  titer	  in	  a	  plaque	  assay	  (detailed	  in	  Methods).	  Data	  points	  are	  an	  average	  of	  2	  replicates.	  	   Acyclovir	  (ACV)	  is	  an	  antiviral	  drug	  commonly	  used	  in	  treatment	  of	  herpesvirus	  infections,	  and	  exerts	  its	  activity	  by	  terminating	  viral	  DNA	  replication.	  Cell	  culture	  models	  of	  HSV	  latency	  often	  rely	  on	  ACV	  to	  suppress	  viral	  replication	  during	  the	  establishment	  phase	  [73,	  74],	  therefore	  it	  was	  determined	  if	  quiescent	  infection	  of	  differentiated	  ONS-­‐76	  cells	  could	  be	  achieved	  through	  use	  of	  this	  chemical.	  Cultures	  incubated	  with	  ACV	  were	  infected	  with	  HSV	  KOS	  and	  V422	  at	  an	  MOI	  of	  1	  and	  viral	  titer	  and	  cellular	  morphology	  were	  again	  monitored	  for	  48	  hours.	  In	  the	  presence	  of	  ACV,	  infectious	  KOS	  and	  V422	  were	  not	  detectable	  beyond	  the	  first	  36	  hours	  of	  infection	  (Figure	  4.8),	  a	  finding	  consistent	  with	  suppressed	  replication.	  Despite	  this	  result,	  infected	  cultures	  developed	  CPE	  similarly	  to	  cultures	  infected	  in	  the	  absence	  of	  ACV,	  with	  a	  progressive	  loss	  of	  most	  cells	  by	  48	  hpi	  (Figure	  4.9).	  V422	  titers	  fell	  more	  quickly	  than	  that	  of	  the	  wild	  type	  and	  V422-­‐infected	  cells	  appeared	  to	  survive	  longer	  than	  those	  infected	  with	  KOS,	  attributable	  again	  to	  the	  impairment	  of	  the	  mutant,	  however	  the	  overall	  phenotype	  was	  the	  same	  for	  both	  viruses.	  As	  infection	  with	  HSV	  KOS	  and	  V422	  caused	  significant	  toxicity	  to	  differentiated	  ONS-­‐76	  cells	  even	  in	  the	  absence	  of	  viral	  replication,	  it	  was	  concluded	  that	  this	  system	  was	  not	  compatible	  with	  hosting	  HSV	  latency.	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Figure	  4.8	  HSV	  replication	  in	  differentiated	  ONS-­76	  cells	  (+ACV)	  ONS-­‐76	  cells	  were	  differentiated	  in	  6-­‐well	  plates	  and	  incubated	  with	  100µM	  ACV	  beginning	  24	  hours	  prior	  to	  infection.	  Infection	  by	  HSV	  strain	  KOS	  or	  V422	  was	  performed	  at	  an	  MOI	  of	  1,	  and	  at	  the	  indicated	  time	  point	  cells	  were	  removed	  from	  the	  wells	  by	  scraping	  and	  processed	  for	  use	  in	  a	  plaque	  assay.	  ACV	  pressure	  was	  maintained	  throughout	  the	  experiment.	  Data	  points	  are	  an	  average	  of	  2	  replicates.	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Figure	  4.9	  Morphology	  of	  differentiated	  ONS-­76	  cells	  during	  infection	  ONS-­‐76	  cells	  were	  differentiated	  in	  6-­‐well	  plates	  and	  infected	  with	  the	  indicated	  HSV	  strain	  at	  an	  MOI	  of	  1.	  At	  the	  indicated	  time	  point,	  cell	  cultures	  were	  visualized	  by	  confocal	  microscopy.	  Pictures	  depict	  a	  representative	  sample	  of	  cells	  in	  culture.	  A:	  KOS	  and	  V422	  infection	  of	  differentiated	  ONS-­‐76	  cells	  B:	  KOS	  and	  V422	  infection	  of	  differentiated	  ONS-­‐76	  cells	  in	  the	  presence	  of	  100µM	  ACV.	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4.2.2 Establishing	  quiescent	  HSV	  infection	  of	  differentiated	  UW228	  cells	  It	  was	  also	  determined	  if	  differentiated	  UW228	  cells	  could	  support	  quiescent	  infection	  with	  wild	  type	  or	  mutant	  HSV.	  To	  resolve	  this,	  UW228	  cells	  were	  differentiated	  and	  infected	  with	  HSV	  KOS	  or	  V422	  at	  an	  MOI	  of	  1.	  Infection	  was	  performed	  in	  the	  presence	  of	  ACV,	  and	  both	  viral	  titer	  and	  culture	  morphology	  were	  monitored	  over	  a	  seven	  day	  period.	  Titers	  of	  both	  KOS	  and	  V422	  declined	  to	  undetectable	  levels	  as	  time	  progressed	  (Figure	  4.10),	  with	  this	  process	  occurring	  more	  slowly	  than	  what	  was	  seen	  in	  infection	  of	  ONS-­‐76	  cells	  (Figure	  4.8).	  Infectious	  V422	  became	  undetectable	  by	  day	  4	  post	  infection,	  while	  KOS	  was	  found	  in	  cultures	  until	  day	  7	  (Figure	  4.10).	  In	  KOS-­‐infected	  cultures,	  CPE	  was	  observed	  to	  slowly	  spread	  throughout,	  with	  the	  vast	  majority	  of	  cells	  being	  lost	  by	  day	  7	  (Figure	  4.11,	  top).	  In	  V422-­‐infected	  cultures	  there	  was	  relatively	  minor	  development	  of	  CPE,	  and	  while	  cell	  density	  did	  initially	  decrease,	  viable	  cells	  were	  still	  abundant	  on	  day	  7	  (Figure	  4.11,	  bottom).	  Based	  on	  this	  data	  differentiated	  cultures	  of	  UW228	  cells	  appeared	  to	  tolerate	  infection	  with	  V422	  and	  the	  virus	  was	  further	  investigated	  in	  this	  system.	  
	  
Figure	  4.10	  HSV	  replication	  in	  differentiated	  UW228	  cells	  UW228	  cells	  were	  differentiated	  in	  6-­‐well	  plates	  and	  incubated	  with	  100µM	  ACV	  beginning	  24	  hours	  prior	  to	  infection.	  HSV	  KOS	  and	  V422	  were	  used	  to	  infect	  UW228	  cells	  at	  an	  MOI	  of	  1,	  and	  cells	  were	  harvested	  by	  scraping	  at	  the	  indicated	  time	  points.	  ACV	  pressure	  was	  maintained	  throughout	  the	  experiment,	  with	  culture	  media	  being	  refreshed	  on	  days	  3	  and	  6.	  Detection	  of	  infectious	  virus	  was	  by	  plaque	  assay.	  Day	  0	  sample	  was	  harvested	  following	  the	  1h	  incubation	  of	  input	  virus.	  Data	  points	  represent	  an	  average	  of	  2	  replicates.	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Figure	  4.11	  Morphology	  of	  HSV-­infected	  differentiated	  UW228	  cells	  Differentiated	  UW228	  cells	  were	  infected	  with	  HSV	  KOS	  or	  V422	  at	  an	  MOI	  of	  1	  in	  the	  presence	  of	  100µM	  ACV.	  ACV	  pressure	  was	  maintained	  throughout,	  and	  media	  was	  refreshed	  on	  days	  3	  and	  6.	  At	  the	  indicated	  time	  point	  cultures	  were	  visualized	  by	  confocal	  microscopy.	  Images	  depict	  a	  representative	  sample	  of	  infected	  cells.	  Top:	  Infection	  of	  differentiated	  UW228	  cells	  with	  KOS.	  Bottom:	  Infection	  of	  differentiated	  UW228	  cells	  with	  V422.	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   As	  HSV	  V422	  infection	  appeared	  to	  have	  limited	  toxicity	  on	  differentiated	  UW228	  cells,	  viral	  transcription	  was	  assessed	  to	  characterize	  if	  this	  infection	  was	  consistent	  with	  quiescence.	  Transcription	  from	  the	  IE	  class	  gene	  ICP0,	  E	  class	  gene	  thymidine	  kinase	  (TK),	  and	  L	  class	  genes	  VP5	  and	  VP16	  was	  quantified	  by	  qRT-­‐PCR	  to	  determine	  if	  lytic	  gene	  expression	  occurred.	  Expression	  from	  the	  LAT	  locus	  was	  also	  quantified,	  as	  the	  presence	  of	  this	  transcript	  correlates	  strongly	  with	  latency.	  All	  investigated	  lytic	  genes	  demonstrated	  increases	  ordered	  according	  to	  temporal	  class	  within	  the	  first	  10	  hours,	  with	  detection	  gradually	  decreasing	  to	  low	  or	  undetectable	  levels	  over	  the	  following	  4	  days	  (Figure	  4.12).	  Transcription	  after	  day	  4	  was	  not	  observed	  for	  ICP0,	  VP5,	  and	  VP16,	  while	  low	  levels	  of	  TK	  transcripts	  continued	  to	  be	  detected	  even	  at	  7	  dpi	  (Figure	  4.12).	  The	  LAT	  was	  not	  detected	  throughout	  the	  course	  of	  this	  experiment	  (Figure	  4.12),	  however	  this	  result	  must	  be	  interpreted	  with	  caution	  as	  a	  positive	  control	  was	  not	  performed.	  As	  LAT	  expression	  is	  not	  strictly	  required	  to	  model	  latency,	  the	  pattern	  of	  lytic	  gene	  transcription	  observed	  in	  HSV	  V422	  infection	  of	  differentiated	  UW228	  cells	  was	  concluded	  to	  be	  consistent	  with	  quiescent	  infection.	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Figure	  4.12	  Transcription	  from	  HSV	  V422	  in	  differentiated	  UW228	  cells	  Differentiated	  UW228	  cells	  were	  infected	  with	  HSV	  V422	  at	  an	  MOI	  of	  1	  in	  the	  presence	  of	  ACV	  and	  transcription	  from	  the	  virus	  was	  monitored	  for	  a	  7	  day	  period.	  At	  the	  indicated	  time	  points,	  supernatant	  was	  removed	  from	  wells	  and	  cells	  were	  harvested.	  RNA	  was	  isolated,	  quantified,	  converted	  to	  cDNA	  and	  quantified	  by	  qRT-­‐PCR	  according	  to	  the	  protocol	  outlined	  in	  Methods.	  Gene	  equivalents	  for	  Ct	  values	  were	  generated	  through	  the	  use	  of	  standard	  curves	  specific	  to	  each	  primer	  set.	  Two	  wells	  were	  harvested	  for	  each	  time	  point	  and	  qRT-­‐PCR	  was	  performed	  in	  duplicate,	  points	  represent	  the	  average	  of	  these	  data.	  	  	   The	  results	  insofar	  depict	  HSV	  V422	  infection	  of	  differentiated	  UW228	  cells	  to	  be	  consistent	  with	  quiescence,	  as	  this	  system	  features	  the	  disappearance	  of	  lytic	  transcription	  and	  viral	  replication	  after	  an	  initial	  period	  of	  detection.	  To	  confirm	  that	  the	  HSV	  genome	  endured	  in	  the	  absence	  of	  infectious	  virus	  and	  lytic	  expression,	  the	  persistence	  of	  HSV	  DNA	  in	  long-­‐term	  infection	  was	  investigated.	  Cultures	  of	  differentiated	  UW228	  cells	  were	  infected	  with	  HSV	  V422,	  and	  the	  amount	  of	  viral	  DNA	  was	  quantified	  in	  total	  DNA	  over	  a	  12	  day	  period.	  Detection	  of	  V422	  was	  observed	  to	  gradually	  decline	  as	  infection	  progressed,	  with	  the	  number	  of	  genomes	  being	  reduced	  by	  half	  between	  day	  3	  and	  day	  12	  (Figure	  4.13).	  The	  number	  of	  genomes	  detected	  following	  inoculation	  was	  2.2x106	  per	  million	  cells,	  therefore	  by	  day	  3	  only	  1.47%	  of	  the	  input	  virus	  was	  detectable.	  This	  result	  confirms	  that	  viral	  DNA	  persists	  beyond	  the	  disappearance	  of	  infectious	  virus	  and	  lytic	  transcription,	  consistent	  with	  quiescence,	  however	  only	  a	  small	  fraction	  of	  input	  virus	  is	  detectable	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throughout	  long-­‐term	  infection.	  As	  the	  frequency	  of	  persisting	  genomes	  was	  low,	  the	  conformation	  of	  the	  remaining	  virus	  was	  investigated	  to	  determine	  if	  it	  was	  consistent	  with	  other	  defining	  characteristics	  of	  latency.	  	  
	  
Figure	  4.13	  Persistence	  of	  HSV	  V422	  in	  differentiated	  UW228	  cells	  Differentiated	  UW228	  cells	  were	  infected	  with	  HSV	  V422	  at	  an	  MOI	  of	  1	  in	  the	  presence	  of	  ACV.	  ACV	  pressure	  was	  maintained	  throughout,	  and	  media	  was	  refreshed	  on	  days	  3,	  6,	  and	  9.	  At	  the	  indicated	  time	  point,	  cells	  were	  harvested	  by	  scraping	  and	  processed	  to	  isolate	  total	  DNA.	  Viral	  and	  cellular	  targets	  (VP16	  and	  ZF)	  were	  quantified	  by	  qRT-­‐PCR	  as	  detailed	  in	  Methods.	  Gene	  equivalent	  was	  determined	  through	  the	  use	  of	  standard	  curves	  generated	  for	  each	  specific	  primer	  set.	  The	  presence	  of	  viral	  target	  was	  not	  detected	  in	  mock	  infected	  cultures.	  Input	  virus	  detectable	  after	  inoculation	  procedure	  was	  2.2x106	  viral	  genomes	  per	  million	  cells.	  Two	  wells	  were	  harvested	  for	  each	  time	  point	  and	  qRT-­‐PCR	  was	  performed	  in	  duplicate	  for	  cellular	  and	  viral	  targets,	  points	  represent	  the	  average	  of	  these	  data.	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   The	  HSV	  genome	  is	  thought	  to	  exist	  as	  a	  circular	  episome	  during	  latent	  infection	  [28],	  and	  Gardella	  gels	  have	  long	  been	  used	  as	  a	  means	  of	  distinguishing	  the	  circular	  form	  of	  latent	  herpesviruses	  from	  other	  conformations	  [119].	  Therefore,	  a	  Gardella	  gel	  was	  run	  in	  an	  attempt	  to	  distinguish	  whether	  the	  HSV	  genomes	  present	  in	  long-­‐term	  infection	  of	  differentiated	  UW228	  cells	  existed	  in	  a	  conformation	  characteristic	  of	  latent	  infection.	  	  	  
	  
Figure	  4.14	  Gardella	  gel	  Image	  of	  Gardella	  gel	  post-­‐electrophoresis	  with	  UV	  illumination.	  Gardella	  gel	  was	  prepared	  and	  electrophoresed	  according	  to	  the	  procedure	  detailed	  in	  Methods.	  Bands	  represent	  cellular	  genomic	  DNA	  from	  loaded	  wells,	  O	  represents	  the	  approximate	  expected	  location	  of	  circularized	  HSV	  detection,	  and	  I	  represents	  the	  approximate	  expected	  location	  of	  linear	  HSV	  detection	  [105].	  Each	  loaded	  lane	  was	  cut	  into	  0.5cm	  sequential	  slices,	  with	  slice	  1	  containing	  the	  bottom	  of	  the	  Gardella	  gel	  wells,	  then	  used	  as	  template	  in	  PCR	  reactions.	  	  	   Cultures	  of	  differentiated	  UW228	  cells	  representing	  day	  0,	  7,	  14,	  and	  21	  post	  HSV	  V422	  infection	  were	  prepared	  and	  run	  in	  a	  Gardella	  gel	  as	  shown	  in	  Figure	  4.14.	  Cultures	  of	  Vero	  cells	  infected	  for	  6	  hours	  with	  the	  HSV	  mutant	  n212	  were	  included	  in	  this	  experiment,	  as	  this	  mutant	  has	  been	  demonstrated	  to	  adopt	  a	  circular	  format	  under	  such	  conditions	  [28].	  PCR	  for	  detection	  of	  HSV	  DNA	  was	  performed	  on	  slices	  generated	  from	  individual	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lanes	  of	  the	  Gardella	  gel,	  and	  reaction	  products	  visualized	  on	  agarose	  gels.	  HSV	  DNA	  was	  detected	  in	  slices	  27-­‐29,	  corresponding	  to	  approximately	  14cm	  from	  the	  Gardella	  gel	  wells	  (Figure	  4.15,	  Figure	  4.16),	  which	  is	  consistent	  with	  migration	  of	  the	  linear	  form	  [105].	  Viral	  DNA	  was	  detected	  in	  this	  region	  for	  day	  0	  and	  7	  cultures	  as	  well	  as	  n212	  infection	  (Figure	  4.15,	  Figure	  4.16),	  but	  was	  not	  detected	  in	  day	  14	  and	  21	  cultures	  (Figure	  4.16).	  The	  circular	  form	  of	  HSV	  migrates	  more	  slowly	  than	  the	  linear	  form	  and	  was	  expected	  to	  be	  detected	  approximately	  5-­‐6cm	  from	  the	  wells	  [105].	  None	  of	  the	  PCR	  reactions	  performed	  on	  this	  region	  returned	  products,	  however,	  including	  those	  from	  this	  region	  of	  the	  HSV	  n212	  positive	  control.	  Several	  of	  the	  lanes	  returned	  non-­‐specific	  bands	  migrating	  at	  slightly	  less	  than	  100bp,	  however	  only	  the	  bands	  migrating	  at	  275bp	  represent	  the	  specific	  PCR	  product.	  As	  the	  amount	  of	  virus	  present	  in	  the	  tested	  cultures	  proved	  to	  be	  below	  the	  threshold	  of	  detection	  by	  the	  Gardella	  gel,	  no	  conclusion	  could	  be	  reached	  on	  the	  conformation	  of	  HSV	  V422	  in	  long-­‐term	  infection	  of	  differentiated	  UW228	  cells.	  	  
	   47	  
	  
Figure	  4.15	  Detection	  of	  n212	  in	  Vero	  cells	  by	  Gardella	  gel	  Vero	  cells	  were	  seeded	  into	  6-­‐well	  plates	  at	  a	  density	  of	  2x105	  cells/well	  and	  allowed	  to	  reach	  confluence.	  24	  hours	  prior	  to	  infection,	  media	  containing	  100µM	  ACV	  was	  added.	  The	  HSV	  mutant	  n212	  was	  used	  to	  infect	  the	  Vero	  cells	  at	  an	  MOI	  of	  3	  and	  infection	  was	  allowed	  to	  progress	  for	  6	  hours	  before	  cultures	  were	  prepared	  and	  loaded	  into	  the	  Gardella	  gel.	  Slices	  from	  the	  Gardella	  gel	  lane	  containing	  n212-­‐infected	  Vero	  cells	  were	  used	  as	  template	  in	  PCR	  reactions	  as	  detailed	  in	  Methods,	  and	  products	  from	  these	  reactions	  were	  electrophoresed	  on	  the	  pictured	  agarose	  gel.	  Lanes	  marked	  L	  contain	  100bp	  ladder.	  Lane	  numbers	  indicate	  the	  Gardella	  gel	  slice	  used	  as	  template	  and	  contain	  PCR	  reaction	  products.	  Lane	  N	  contains	  products	  from	  the	  control	  (no	  template)	  PCR	  reaction.	  Slice	  17	  reaction	  products	  contain	  a	  non-­‐specific	  band	  of	  <100bp.	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Figure	  4.16	  Detection	  of	  V422	  in	  UW228	  cells	  by	  Gardella	  gel	  UW228	  cells	  were	  differentiated	  and	  infected	  with	  HSV	  V422	  at	  an	  MOI	  of	  1	  in	  the	  presence	  of	  ACV.	  Infection	  was	  allowed	  to	  progress	  for	  the	  indicated	  time	  intervals	  with	  maintained	  ACV	  pressure	  before	  cells	  were	  prepared	  and	  loaded	  into	  the	  Gardella	  gel.	  Slices	  from	  the	  appropriate	  Gardella	  gel	  lanes	  were	  used	  as	  template	  in	  PCR	  reactions	  as	  detailed	  in	  Methods,	  and	  products	  from	  these	  reactions	  were	  electrophoresed	  on	  the	  pictured	  agarose	  gels.	  Day	  0:	  Lanes	  marked	  L	  contain	  100bp	  ladder.	  Lane	  numbers	  indicate	  the	  Gardella	  gel	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slice	  used	  as	  template	  and	  contain	  PCR	  reaction	  products.	  Lane	  N	  contains	  products	  from	  the	  control	  (no	  template)	  PCR	  reaction.	  Specific	  band	  is	  indicated	  by	  white	  arrowhead.	  Day	  7:	  Lane	  L	  contains	  100bp	  ladder,	  numbered	  lanes	  contain	  products	  from	  slices	  26-­‐29.	  Specific	  band	  is	  indicated	  by	  white	  arrowhead.	  Day	  14:	  Products	  from	  slices	  27-­‐29,	  lane	  N	  contains	  products	  from	  no	  template	  PCR	  reaction.	  Day	  21:	  Products	  from	  slices	  20-­‐29.	  Lane	  L	  contains	  100bp	  ladder,	  lane	  N	  contains	  products	  from	  no	  template	  PCR	  reaction.	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4.3 Reactivation	  of	  HSV	  in	  differentiated	  medulloblastoma	  cells	  	   The	  third	  aim	  of	  this	  project	  was	  to	  determine	  if	  HSV	  reactivation	  could	  be	  modeled	  in	  differentiated	  medulloblastoma	  cells.	  Drawing	  on	  recent	  reports	  indicating	  distinct	  profiles	  of	  HSV	  transcription	  in	  productive	  infection	  and	  reactivation	  [62,	  63],	  it	  was	  evaluated	  if	  differentiated	  ONS-­‐76	  cells	  could	  simulate	  the	  environment	  of	  a	  neuron	  post-­‐reactivation	  stress.	  Long-­‐term	  HSV	  infection	  of	  differentiated	  UW228	  cells	  was	  also	  evaluated	  for	  reactivation	  using	  a	  similar	  approach	  to	  what	  has	  been	  described	  in	  the	  PC-­‐12	  cell	  model	  [84].	  
4.3.1 Reactivation-­‐type	  transcription	  in	  differentiated	  ONS-­‐76	  cells	  	   ONS-­‐76	  cells	  demonstrated	  differentiation	  along	  a	  neuronal	  pathway	  (Section	  4.1),	  however	  proved	  unsuitable	  for	  hosting	  long-­‐term	  HSV	  infection	  (Section	  4.2.1).	  As	  tumour	  cells	  must	  inherently	  deal	  with	  genotoxic	  and	  metabolic	  stresses,	  one	  explanation	  for	  the	  incompatibility	  of	  HSV	  quiescence	  with	  differentiated	  ONS-­‐76	  cells	  is	  that	  these	  cells	  are	  locked	  in	  a	  state	  of	  stress.	  To	  explore	  this	  hypothesis	  it	  was	  determined	  if	  HSV	  infection	  of	  differentiated	  ONS-­‐76	  cells	  resembled	  reactivation.	  It	  has	  been	  shown	  that	  HSV	  undergoing	  reactivation	  deviates	  from	  the	  temporal	  transcription	  cascade	  of	  productive	  infection,	  with	  simultaneous	  expression	  from	  all	  lytic	  gene	  classes	  [62].	  To	  determine	  the	  HSV	  gene	  expression	  profile	  in	  this	  system,	  differentiated	  ONS-­‐76	  cells	  were	  infected	  with	  HSV	  KOS	  or	  V422	  at	  an	  MOI	  of	  1	  and	  lytic	  gene	  expression	  was	  assessed	  by	  qRT-­‐PCR.	  As	  HSV	  undergoes	  productive	  replication	  in	  MRC-­‐5	  cells,	  infection	  in	  this	  cell	  line	  served	  as	  a	  control	  example	  of	  lytic	  expression.	  	   During	  lytic	  HSV	  infection	  transcription	  proceeds	  from	  IE	  to	  E	  to	  L	  gene	  classes,	  and	  this	  order	  was	  observed	  during	  infection	  of	  MRC-­‐5	  cells	  with	  wild	  type	  virus	  (Figure	  4.17,	  top).	  ICP0,	  from	  the	  IE	  class,	  reached	  its	  maximum	  at	  2hpi	  followed	  by	  TK	  (E)	  at	  4hpi	  and	  VP5/VP16	  (L)	  at	  6hpi.	  This	  pattern	  of	  transcription	  was	  also	  observed	  in	  KOS	  infection	  of	  differentiated	  ONS-­‐76	  cells	  (Figure	  4.17,	  bottom),	  with	  lytic	  transcripts	  reaching	  maximum	  values	  in	  the	  same	  temporal	  order	  as	  in	  MRC-­‐5	  cells.	  In	  HSV	  V422	  the	  activation	  domain	  of	  VP16	  is	  deleted,	  preventing	  the	  virus	  from	  counteracting	  intrinsic	  cellular	  repression	  of	  IE	  gene	  transcription,	  and	  blocking	  entry	  into	  the	  lytic	  expression	  cascade.	  HSV	  V422	  infection	  of	  MRC-­‐5	  cells	  exhibited	  low	  levels	  of	  transcription	  from	  all	  lytic	  gene	  classes,	  which	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decreased	  from	  initial	  detection	  levels	  as	  time	  progressed	  (Figure	  4.18,	  top).	  This	  result	  is	  expected	  to	  be	  observed	  if,	  in	  the	  absence	  of	  VP16	  induction,	  the	  virus	  is	  unable	  to	  overcome	  the	  barrier	  to	  transcription	  enacted	  by	  cellular	  repression	  mechanisms.	  In	  contrast,	  infection	  of	  differentiated	  ONS-­‐76	  cells	  with	  V422	  resulted	  in	  a	  simultaneous	  increase	  in	  transcription	  from	  all	  classes	  occurring	  at	  4hpi	  (Figure	  4.18,	  bottom).	  This	  gene	  expression	  profile	  is	  consistent	  with	  what	  has	  been	  observed	  during	  HSV	  reactivation	  in	  other	  systems	  [62,	  63],	  and	  is	  the	  first	  indication	  that	  reactivation-­‐type	  replication	  may	  be	  modeled	  in	  cell	  culture	  without	  requirement	  for	  latency	  establishment	  and	  maintenance.	  	  
	  
Figure	  4.17	  Gene	  expression	  of	  HSV	  KOS	  in	  differentiated	  ONS-­76	  and	  MRC-­5	  cells	  ONS-­‐76	  cells	  were	  differentiated	  in	  and	  MRC-­‐5	  cells	  were	  allowed	  to	  reach	  confluence	  in	  6-­‐well	  plates.	  Cultures	  were	  infected	  with	  HSV	  KOS	  at	  an	  MOI	  of	  1	  and	  transcription	  from	  the	  virus	  was	  monitored	  over	  the	  following	  6	  hour	  period.	  At	  the	  indicated	  time	  points	  the	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supernatant	  was	  removed	  and	  cells	  were	  harvested.	  RNA	  was	  isolated,	  quantified,	  and	  converted	  to	  cDNA	  as	  described	  in	  Methods.	  qRT-­‐PCR	  was	  performed	  on	  a	  standardized	  amount	  of	  cDNA	  for	  each	  of	  the	  genes	  depicted,	  and	  Ct	  values	  were	  converted	  to	  gene	  equivalent	  through	  use	  of	  primer-­‐specific	  standard	  curves.	  Data	  represents	  an	  average	  of	  duplicate	  PCR	  reactions	  from	  two	  wells	  per	  time	  point.	  Top:	  transcription	  from	  KOS	  in	  MRC-­‐5	  cells.	  Bottom:	  transcription	  from	  KOS	  in	  differentiated	  ONS-­‐76	  cells.	  	  
	  
Figure	  4.18	  Gene	  expression	  of	  HSV	  V422	  in	  differentiated	  ONS-­76	  and	  MRC-­5	  cells	  ONS-­‐76	  cells	  were	  differentiated	  in	  and	  MRC-­‐5	  cells	  were	  allowed	  to	  reach	  confluency	  in	  6-­‐well	  plates.	  Cultures	  were	  infected	  with	  HSV	  V422	  at	  an	  MOI	  of	  1	  and	  transcription	  from	  the	  virus	  was	  monitored	  over	  the	  following	  6	  hour	  period.	  At	  the	  indicated	  time	  points	  the	  supernatant	  was	  removed	  and	  cells	  were	  harvested.	  RNA	  was	  isolated,	  quantified,	  and	  converted	  to	  cDNA	  as	  described	  in	  Methods.	  qRT-­‐PCR	  was	  performed	  on	  a	  standardized	  amount	  of	  cDNA	  for	  each	  of	  the	  genes	  depicted,	  and	  Ct	  values	  were	  converted	  to	  gene	  equivalent	  through	  use	  of	  primer-­‐specific	  standard	  curves.	  Data	  represents	  an	  average	  of	  duplicate	  PCR	  reactions	  from	  two	  wells	  per	  time	  point.	  Top:	  transcription	  from	  V422	  in	  MRC-­‐5	  cells.	  Bottom:	  transcription	  from	  V422	  in	  differentiated	  ONS-­‐76	  cells.	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4.3.2 Reactivation	  from	  quiescence	  in	  differentiated	  UW228	  cells	  	   Viral	  genomes	  were	  shown	  to	  persist	  in	  V422	  infection	  of	  differentiated	  UW228	  cells	  (Section	  4.2.2),	  and	  this	  virus	  was	  assessed	  for	  the	  ability	  to	  respond	  to	  reactivation	  stimuli	  by	  re-­‐entering	  the	  replicative	  cycle.	  Figure	  4.19	  outlines	  the	  procedure	  used	  for	  the	  reactivation	  experiments	  detailed	  herein.	  Briefly,	  long-­‐term	  V422	  infection	  of	  differentiated	  UW228	  cells	  was	  established	  and	  the	  virus	  subjected	  to	  a	  variety	  of	  reactivation	  stimuli.	  Total	  DNA	  was	  purified	  from	  cultures	  for	  7	  days	  following	  reactivation	  stress,	  and	  cellular	  and	  viral	  targets	  in	  the	  harvested	  DNA	  were	  quantified	  by	  qRT-­‐PCR.	  In	  this	  manner,	  viral	  DNA	  amplification	  in	  response	  to	  reactivation	  stress	  could	  be	  used	  as	  a	  sensitive	  assessment	  of	  reactivation.	  	  	  
	  
Figure	  4.19	  Outline	  of	  reactivation	  experiments	  	   	  Reactivation	  stress	  was	  achieved	  by	  exposure	  to	  forskolin	  or	  trichostatin	  A	  (TSA),	  superinfection	  with	  UV-­‐inactivated	  HSV,	  transfection	  with	  an	  adenovirus	  expression	  vector	  carrying	  Luman	  (Ad.Luman)	  or	  LacZ	  (Ad.LacZ),	  and	  heat	  shock.	  Forskolin,	  TSA,	  and	  heat	  shock	  are	  common	  methods	  of	  inducing	  HSV	  reactivation	  [74,	  120,	  121],	  while	  superinfection	  with	  UV-­‐inactivated	  HSV	  was	  used	  to	  deliver	  wild-­‐type	  VP16	  protein	  to	  the	  quiescent	  virus.	  Luman	  is	  a	  cellular	  homologue	  of	  VP16	  that	  can	  activate	  IE	  gene	  expression	  under	  certain	  conditions	  [122],	  and	  was	  included	  as	  a	  potential	  reactivation	  stimulus.	  Antiviral	  pressure	  was	  removed	  at	  the	  time	  of	  exposure	  to	  reactivation	  stimuli	  to	  permit	  viral	  DNA	  replication,	  and	  V422-­‐permissive	  U2OS	  cells	  were	  seeded	  into	  the	  infected	  UW228	  cultures	  post-­‐stress	  to	  amplify	  successful	  reactivation	  events.	  As	  the	  differentiation	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agents	  DBcAMP	  and	  NGF	  were	  selectively	  toxic	  to	  the	  overlaid	  U2OS	  cells,	  these	  chemicals	  were	  not	  maintained	  in	  culture	  media	  following	  reactivation	  stress.	  	   Three	  outcomes	  were	  observed	  in	  cultures	  following	  reactivation	  stress:	  no	  change	  in	  cell	  density	  or	  morphology,	  some	  decrease	  in	  cell	  density	  accompanied	  by	  scattered	  cells	  displaying	  CPE,	  or	  death	  of	  the	  majority	  of	  cells	  in	  culture.	  Stress	  stimuli	  resulting	  in	  culture	  death	  included	  treatment	  with	  TSA	  and	  transfection	  with	  Ad.Luman	  (Figure	  4.20A).	  Both	  treatments	  resulted	  in	  the	  vast	  majority	  of	  cells	  becoming	  round	  and	  detaching	  from	  the	  plate	  surface,	  a	  phenomenon	  consistent	  with	  cell	  death,	  within	  3	  days	  of	  reactivation	  stress.	  Treatments	  which	  appeared	  to	  have	  no	  effect	  on	  culture	  morphology	  included	  removal	  of	  differentiating	  agents	  alone,	  and	  application	  of	  forskolin	  (Figure	  4.20B).	  Cultures	  in	  these	  treatment	  groups	  exhibited	  identical	  morphology	  on	  days	  0	  and	  7	  post	  reactivation,	  with	  similar	  or	  slightly	  increased	  cell	  densities.	  Finally,	  treatment	  with	  UV-­‐inactivated	  HSV,	  Ad.LacZ,	  and	  heat	  shock	  resulted	  in	  some	  decrease	  in	  cell	  density	  with	  scattered	  cells	  displaying	  CPE	  (Figure	  4.20C).	  Substantially	  more	  CPE	  was	  observed	  in	  cultures	  superinfected	  with	  UV-­‐inactivated	  HSV	  over	  the	  other	  treatments.	  Prior	  to	  this	  study	  the	  radiation	  dose	  required	  to	  fully	  inactivate	  the	  virus	  was	  determined.	  In	  this	  experiment	  however,	  controls	  containing	  only	  UV-­‐inactivated	  HSV	  demonstrated	  the	  same	  spreading	  CPE	  as	  test	  cultures.	  This	  result	  indicates	  that	  the	  UV-­‐inactivated	  virus	  stock	  retained	  residual	  replicative	  ability,	  obscuring	  the	  effects	  of	  providing	  wild	  type	  VP16	  to	  the	  V422	  genome.	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Figure	  4.20	  Morphology	  of	  V422-­infected	  UW228	  cells	  following	  reactivation	  stimuli	  UW228	  cells	  were	  differentiated	  and	  infected	  with	  HSV	  V422	  as	  outlined	  in	  Figure	  4.19.	  U2OS	  cells	  were	  overlaid	  at	  a	  density	  of	  2x105	  cells/well	  following	  stress	  treatment.	  Images	  were	  captured	  daily	  for	  7	  days	  after	  reactivation	  stimulus	  (reactivation	  day	  0)	  and	  depict	  a	  representative	  sample	  of	  the	  visualized	  cultures.	  A:	  reactivation	  treatments	  resulting	  in	  cell	  death.	  B:	  reactivation	  treatments	  with	  no	  discernable	  effect	  on	  culture	  morphology.	  C:	  reactivation	  treatments	  resulting	  in	  loss	  of	  cell	  density	  and	  CPE.	  Note:	  Forskolin-­‐treated	  UW228	  cells	  were	  not	  overlaid	  with	  U2OS	  cells.	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The	  number	  of	  HSV	  genomes	  present	  in	  V422-­‐infected	  UW228	  cultures	  post-­‐reactivation	  was	  examined	  to	  assess	  if	  stress	  treatment	  induced	  viral	  DNA	  amplification.	  The	  cell	  death	  observed	  following	  treatment	  with	  TSA	  and	  transfection	  with	  Ad.Luman	  was	  not	  accompanied	  by	  a	  substantial	  increase	  in	  viral	  genomes	  (Figure	  4.20A,	  Figure	  4.21,	  Table	  4.3).	  Conversely,	  removal	  of	  differentiating	  agents	  from	  cultures	  did	  not	  appear	  to	  result	  in	  the	  development	  of	  CPE	  (Figure	  4.20B)	  yet	  an	  increase	  in	  viral	  DNA	  was	  observed	  by	  day	  7	  (Figure	  4.21,	  Table	  4.3).	  A	  plaque	  assay	  was	  performed	  on	  lysates	  of	  forskolin-­‐treated	  cells	  to	  determine	  if	  this	  reactivation	  stimulus	  resulted	  in	  the	  emergence	  of	  infectious	  virus.	  Infectious	  virus	  was	  not	  detected,	  and	  the	  more	  limited	  sensitivity	  of	  the	  plaque	  assay	  precludes	  comparison	  to	  treatments	  assessed	  by	  PCR.	  Heat	  shock	  induced	  the	  greatest	  amplification	  of	  viral	  DNA	  (Figure	  4.21),	  consistent	  with	  the	  development	  of	  scattered	  CPE	  in	  culture	  morphologies	  (Figure	  4.20C).	  Superinfection	  of	  differentiated	  UW228	  cells	  with	  UV-­‐inactivated	  HSV	  resulted	  in	  a	  substantial	  increase	  in	  viral	  DNA	  (Figure	  4.22,	  Table	  4.3),	  which	  is	  consistent	  with	  indications	  that	  the	  UV-­‐inactivated	  virus	  stock	  retained	  a	  degree	  of	  replicative	  competence.	  Transfection	  with	  Ad.LacZ	  resulted	  in	  some	  elevation	  in	  HSV	  genomes	  detected	  at	  day	  7	  (Figure	  4.21,	  Table	  4.3),	  although	  this	  result	  does	  not	  explain	  the	  initial	  loss	  in	  cell	  density	  and	  development	  of	  CPE	  observed	  in	  culture	  morphologies	  (Figure	  4.20C).	  In	  sum,	  these	  results	  demonstrate	  that	  amplification	  of	  HSV	  V422	  DNA	  in	  differentiated	  UW228	  cells	  occurred	  after	  treatment	  with	  heat	  shock,	  removal	  of	  differentiating	  agents,	  and,	  to	  a	  lesser	  extent,	  after	  transfection	  with	  a	  control	  adenovirus	  expression	  vector.	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Figure	  4.21	  Amplification	  of	  HSV	  V422	  in	  response	  to	  reactivation	  stimuli	  UW228	  cells	  were	  differentiated	  and	  infected	  (day	  0)	  as	  outlined	  in	  Figure	  4.19.	  The	  presence	  of	  HSV	  V422	  in	  cultures	  was	  monitored	  through	  the	  establishment	  phase	  (days	  0-­‐7)	  and	  following	  reactivation	  stimuli	  (days	  7-­‐14)	  by	  extracting	  total	  DNA	  from	  cells	  and	  performing	  qRT-­‐PCR	  as	  detailed	  in	  Methods.	  On	  day	  7	  differentiating	  agents	  and	  ACV	  were	  washed	  out	  and	  cells	  exposed	  to	  the	  indicated	  stress	  treatments,	  following	  which	  2x105	  U2OS	  cells/well	  were	  added	  to	  cultures.	  Treatment	  conditions:	  -­‐diff;	  ACV	  and	  differentiating	  agents	  removed	  from	  cultures	  with	  no	  additional	  stress	  treatment.	  Heat	  shock;	  cultures	  incubated	  at	  43°C	  for	  3h.	  Ad.Luman;	  adenovirus	  expression	  vector	  carrying	  exogenous	  Luman	  infected	  at	  an	  MOI	  of	  100.	  Ad.LacZ;	  same	  conditions	  as	  Ad.Luman.	  TSA;	  60ng/ml	  TSA	  added	  to	  media.	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Figure	  4.22	  Viral	  amplification	  after	  superinfection	  with	  UV-­irradiated	  HSV	  UW228	  cells	  were	  differentiated	  and	  infected	  as	  outlined	  in	  Figure	  4.19.	  For	  reactivation	  stress,	  HSV	  KOS	  stock	  was	  subjected	  to	  1x106µJ/cm2	  UV	  radiation	  in	  a	  Stratagene	  UV	  Stratalinker	  1800	  and	  used	  to	  superinfect	  cultures	  of	  V422-­‐infected	  UW228	  cells	  or	  U2OS	  cells	  at	  an	  MOI	  of	  1	  (as	  calculated	  from	  the	  titer	  of	  non-­‐irradiated	  stock).	  UW228	  cells	  were	  then	  overlaid	  with	  2x105	  U2OS	  cells/well.	  At	  the	  indicated	  time	  points	  cells	  were	  harvested	  by	  scraping	  and	  total	  DNA	  was	  extracted	  and	  processed	  for	  qRT-­‐PCR	  as	  detailed	  in	  Methods.	  Genome	  equivalents	  were	  determined	  by	  standard	  curves	  specific	  to	  each	  primer	  set,	  and	  the	  number	  of	  viral	  DNA	  copies	  per	  million	  cells	  calculated.	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Table	  4.3	  Quantification	  of	  HSV	  and	  UW228	  cells	  after	  exposure	  to	  reactivation	  
stimuli	  Stimulus	   Target	   Initial	  (genome	  equivalent)	   Final	  (genome	  equivalent)	  Viral	   29	   -­‐	  Day	  7	  (pre-­‐stress	  treatment)	   Cellular	   7.4x105	   -­‐	  Viral	   16	   1.4x104	  -­‐ACV/-­‐diff	   Cellular	   6.7x105	   3.5x106	  Viral	   236	   5.6x104	  +UV	  virus	   Cellular	   1.3x106	   6.3x104	  Viral	   17	   2.7x104	  Heat	  shock	   Cellular	   9.4x105	   2.0x106	  Viral	   11	   6	  Ad.Luman	   Cellular	   6.6x105	   4.1x103	  Viral	   11	   4.1x103	  Ad.LacZ	  	   Cellular	   1.4x106	   1.1x106	  Viral	   23	   85	  TSA	   Cellular	   2.9x104	   4.8x103	  Initial	  and	  final	  genome	  equivalents	  observed	  after	  reactivation	  treatments	  (experiment	  detailed	  in	  Figure	  4.21).	  VP16	  (viral	  target)	  and	  ZF	  (cellular	  target)	  copies	  were	  quantified	  in	  total	  DNA	  as	  an	  indication	  of	  the	  number	  of	  viral	  and	  cellular	  genomes	  present.	  Initial	  genome	  equivalents	  represent	  viral	  and	  cellular	  genome	  copies	  detected	  on	  day	  +1	  post	  reactivation	  stress	  (excepting	  day	  7,	  which	  is	  pre-­‐stress	  treatment	  and	  day	  0	  of	  reactivation).	  Final	  genome	  equivalents	  represent	  viral	  and	  cellular	  genome	  copies	  detected	  on	  day	  +7	  following	  reactivation	  or	  the	  last	  day	  cells	  were	  observed	  in	  culture	  (day	  +3	  for	  Ad.Luman	  and	  TSA).	  Two	  wells	  were	  harvested	  for	  each	  treatment	  at	  each	  time	  point	  and	  qRT-­‐PCR	  was	  performed	  in	  duplicate,	  numbers	  represent	  the	  average	  of	  this	  data.	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Chapter	  5 Discussion	  	   One	  strategy	  in	  developing	  in	  vitro	  models	  of	  HSV	  latency	  and	  reactivation	  has	  been	  to	  induce	  neuronal	  differentiation	  from	  a	  proliferating	  precursor	  cell,	  as	  in	  the	  case	  of	  the	  PC-­‐12	  model.	  Medulloblastomas	  originate	  in	  the	  human	  CNS	  and	  can	  be	  induced	  to	  differentiate	  along	  a	  neuronal	  pathway	  [91,	  95,	  96],	  therefore	  cell	  lines	  derived	  from	  these	  tumours	  were	  examined	  for	  their	  use	  as	  a	  model	  of	  HSV	  latency	  and	  reactivation.	  ONS-­‐76	  and	  UW228	  medulloblastoma	  lines	  were	  induced	  to	  differentiate	  and	  the	  parameters	  of	  establishing	  quiescent	  HSV	  infection	  in	  these	  cells	  were	  explored.	  Differentiated	  ONS-­‐76	  cells	  were	  found	  to	  be	  incompatible	  with	  hosting	  quiescent	  HSV	  infection,	  however	  peculiarities	  observed	  in	  the	  behaviour	  of	  HSV	  in	  this	  study	  may	  yield	  significant	  results.	  Differentiated	  UW228	  cells	  were	  found	  to	  be	  capable	  of	  hosting	  quiescent	  HSV	  infection	  that	  could	  further	  be	  induced	  to	  re-­‐enter	  productive	  replication,	  although	  certain	  restrictions	  were	  necessary	  to	  achieve	  this.	  The	  results	  collectively	  demonstrate	  that	  differentiated	  medulloblastoma	  cells	  represent	  another	  perspective	  through	  which	  HSV	  latency	  and	  reactivation	  may	  be	  explored.	  
5.1 Differentiation	  of	  medulloblastoma	  cell	  lines	  	   The	  first	  aim	  of	  this	  project	  was	  to	  develop	  human	  medulloblastoma	  tumour	  cell	  lines	  into	  neuronally	  differentiated	  cells.	  Of	  the	  three	  cell	  lines	  screened	  for	  neuronal	  differentiation	  capacity,	  morphological	  differentiation	  could	  be	  induced	  in	  ONS-­‐76	  and	  UW228	  cells	  (Figure	  4.1,	  Table	  4.2).	  Differentiation	  of	  these	  two	  lines	  was	  characterized	  by	  analyzing	  proliferation	  rate	  (Figure	  4.2,	  Figure	  4.3)	  and	  assessing	  the	  expression	  of	  cell	  type	  marker	  proteins	  (Figure	  4.4,	  Figure	  4.5).	  Cultures	  of	  differentiated	  ONS-­‐76	  cells	  exhibited	  reduced	  proliferation	  as	  compared	  to	  control	  cells	  (Figure	  4.2)	  and	  were	  induced	  to	  express	  the	  neuronal	  protein	  β-­‐tubulin	  upon	  differentiation	  (Figure	  4.4B).	  From	  this	  it	  was	  concluded	  that	  treatment	  with	  a	  combination	  of	  DBcAMP	  and	  resveratrol	  resulted	  in	  neuronal	  differentiation	  of	  ONS-­‐76	  cells.	  Cultures	  of	  differentiated	  UW228	  cells	  also	  exhibited	  reduced	  proliferation	  as	  compared	  to	  control	  cells	  (Figure	  4.3),	  however	  did	  not	  demonstrate	  increased	  expression	  of	  any	  tested	  marker	  protein	  (Figure	  4.4D,	  E,	  Figure	  4.5).	  Based	  on	  the	  observation	  that	  UW228	  cells	  maintained	  expression	  of	  the	  neuron-­‐
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specific	  proteins	  Brn3A	  and	  NeuN	  throughout	  differentiation	  (Figure	  4.5),	  it	  was	  concluded	  that	  these	  cells	  did	  possess	  neuronal	  character	  although	  treatment	  with	  DBcAMP	  and	  NGF	  did	  not	  cause	  further	  progression	  along	  a	  neuronal	  differentiation	  pathway.	  	  	   A	  complicating	  result	  observed	  for	  both	  ONS-­‐76	  and	  UW228	  cells	  was	  the	  ready	  detection	  of	  GFAP,	  a	  protein	  characteristic	  of	  glial	  cells	  (Figure	  4.4).	  The	  original	  reports	  describing	  establishment	  of	  these	  cell	  lines	  note	  an	  absence	  of	  GFAP	  expression	  [110,	  111],	  raising	  the	  possibility	  that	  ONS-­‐76	  and	  UW228	  cells	  used	  in	  this	  study	  may	  have	  since	  migrated	  along	  a	  glial	  differentiation	  pathway.	  Glial	  differentiation	  is	  known	  to	  suppress	  responsiveness	  to	  neuronal	  differentiation	  stimuli	  [95],	  and	  offers	  an	  explanation	  for	  the	  observed	  absence	  of	  neurofilament	  (Figure	  4.4,	  Figure	  4.5).	  Alternatively,	  given	  that	  astrocyte	  precursor	  cells	  undergo	  stellation	  when	  treated	  with	  DBcAMP	  [123,	  124],	  and	  considering	  the	  readily	  apparent	  GFAP	  expression,	  it	  is	  possible	  that	  the	  differentiated	  cells	  of	  this	  study	  more	  accurately	  represent	  astrocytes	  than	  neurons.	  As	  astrocytes	  are	  known	  to	  be	  permissive	  to	  HSV	  infection	  [125,	  126],	  medulloblastoma	  cells	  that	  have	  moved	  towards	  glial	  differentiation	  may	  be	  less	  suitable	  for	  examining	  HSV	  latency	  and	  reactivation.	  Given	  the	  ambiguity	  in	  character	  displayed	  by	  differentiated	  ONS-­‐76	  and	  UW228	  cells,	  a	  clear	  categorization	  cannot	  be	  made	  using	  the	  available	  data.	  As	  proteins	  associated	  with	  neuronal	  cells	  were	  detected,	  indicating	  some	  degree	  of	  neuronal	  bias,	  and	  because	  of	  the	  stability	  of	  the	  differentiated	  cells,	  differentiated	  ONS-­‐76	  and	  UW228	  cells	  were	  nevertheless	  assessed	  for	  their	  compatibility	  with	  hosting	  HSV	  latency.	  
5.2 HSV	  reactivation	  and	  latency	  in	  differentiated	  ONS-­‐76	  cells	  	   The	  medulloblastoma	  cell	  line	  ONS-­‐76	  was	  determined	  to	  differentiate,	  including	  expression	  of	  the	  neuron-­‐associated	  protein	  β-­‐tubulin,	  by	  treatment	  with	  a	  combination	  of	  DBcAMP	  and	  resveratrol.	  The	  differentiated	  ONS-­‐76	  cells	  were	  assessed	  for	  the	  ability	  to	  host	  quiescent	  HSV	  infection.	  While	  treated	  ONS-­‐76	  cells	  were	  found	  incompatible	  with	  use	  as	  a	  model	  of	  HSV	  latency,	  the	  results	  suggest	  these	  cells	  may	  be	  useful	  in	  studying	  reactivation-­‐type	  replication	  of	  the	  virus.	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5.2.1 Establishing	  quiescent	  HSV	  infection	  	   The	  requirements	  for	  establishing	  quiescent	  HSV	  infection	  in	  differentiated	  ONS-­‐76	  cells	  were	  examined	  using	  wild	  type	  (KOS)	  and	  mutant	  (V422)	  viruses.	  When	  differentiated	  cells	  were	  infected,	  HSV	  KOS	  replicated	  as	  in	  a	  permissive	  system	  and	  HSV	  V422	  replicated	  similarly	  to	  the	  wild	  type	  virus	  (Figure	  4.7).	  HSV	  V422	  is	  known	  to	  replicate	  poorly	  in	  non-­‐complementing	  cells	  owing	  to	  the	  loss	  of	  the	  VP16	  activation	  domain	  function	  [87],	  and	  its	  demonstrated	  ability	  to	  replicate	  in	  this	  system	  suggests	  that	  the	  mechanisms	  by	  which	  these	  cells	  repress	  the	  incoming	  virus	  may	  be	  defective—as	  is	  the	  case	  in	  U2OS	  cells	  [127].	  The	  permissive	  state	  of	  U2OS	  cells	  to	  V422	  replication	  has	  been	  linked	  to	  a	  deficit	  in	  inhibitory	  factors	  that	  repress	  the	  incoming	  virus	  in	  untransformed	  cells,	  factors	  which	  are	  presumably	  targeted	  by	  VP16	  under	  normal	  circumstances	  [128].	  Curiously,	  previous	  work	  in	  this	  laboratory	  has	  indicated	  that	  wild	  type	  HSV	  replication	  in	  undifferentiated	  ONS-­‐76	  cells	  is	  restricted	  [129],	  suggesting	  changes	  induced	  by	  differentiation	  may	  facilitate	  viral	  replication.	  The	  use	  of	  viral	  replication	  inhibition	  during	  infection	  caused	  titers	  of	  both	  HSV	  KOS	  and	  V422	  to	  fall	  to	  undetectable	  levels	  within	  the	  first	  36	  hours	  of	  infection	  (Figure	  4.8).	  This	  observation	  is	  consistent	  with	  entry	  into	  quiescence,	  however	  infected	  cultures	  developed	  widespread	  CPE	  and	  cell	  death	  was	  complete	  by	  48hpi	  (Figure	  4.9B).	  Cellular	  toxicity	  in	  the	  absence	  of	  viral	  replication	  is	  known	  to	  be	  mediated	  by	  the	  presence	  of	  IE	  gene	  products,	  which	  are	  synthesized	  even	  in	  the	  absence	  of	  HSV	  DNA	  replication	  [130,	  131].	  From	  these	  observations	  it	  was	  concluded	  that	  cell	  death	  was	  triggered	  by	  HSV	  infection	  of	  differentiated	  ONS-­‐76	  cells	  in	  the	  absence	  of	  viral	  replication,	  and	  this	  system	  was	  therefore	  incompatible	  with	  use	  as	  a	  model	  of	  HSV	  latency.	  
5.2.2 Reactivation-­‐type	  replication	  	   Because	  of	  the	  stress	  inherent	  to	  unregulated	  growth	  and	  carriage	  of	  multiple	  genetic	  aberrations,	  tumour	  cells	  may	  be	  better	  suited	  to	  modeling	  the	  neuronal	  environment	  after	  the	  experience	  of	  reactivation	  stress.	  It	  has	  been	  demonstrated	  that	  HSV	  responds	  to	  reactivation	  stress	  with	  a	  transcription	  profile	  distinct	  from	  that	  of	  lytic	  replication	  [62,	  63],	  therefore	  the	  pattern	  of	  HSV	  transcription	  in	  differentiated	  ONS-­‐76	  cells	  was	  determined.	  HSV	  KOS	  displayed	  a	  pattern	  of	  gene	  expression	  nearly	  identical	  to	  the	  transcription	  profile	  observed	  in	  lytic	  infection	  of	  the	  fibroblast	  cell	  line	  MRC-­‐5	  (Figure	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4.17).	  Following	  infection	  with	  HSV	  V422	  low	  levels	  of	  viral	  transcription	  were	  detected	  in	  MRC-­‐5	  cells	  (Figure	  4.18),	  consistent	  with	  the	  poor	  growth	  of	  VP16	  AD	  mutants	  observed	  in	  most	  cell	  lines	  [132].	  During	  infection	  of	  differentiated	  ONS-­‐76	  cells	  by	  HSV	  V422	  however,	  transcripts	  accumulated	  from	  all	  kinetic	  gene	  classes	  simultaneously	  (Figure	  4.18).	  This	  finding	  appears	  to	  contrast	  with	  the	  accumulation	  of	  HSV	  V422	  transcripts	  in	  the	  permissive	  U2OS	  cell	  line,	  where	  ordered	  lytic	  gene	  expression	  is	  observed	  [127],	  suggesting	  that	  reactivation-­‐type	  viral	  expression	  may	  be	  occurring	  in	  differentiated	  ONS-­‐76	  cells.	  This	  would	  represent	  a	  novel	  system	  for	  the	  study	  of	  stress	  and	  HSV	  reactivation	  induction;	  however	  reaching	  a	  firm	  conclusion	  entails	  resolving	  the	  requirement	  of	  early	  and	  late	  gene	  transcription	  for	  the	  immediate-­‐early	  proteins	  in	  these	  results.	  In	  the	  expression	  profiling	  experiments	  detailed	  herein,	  a	  relatively	  large	  number	  of	  viral	  transcripts	  were	  detected	  at	  time	  0	  for	  both	  viruses	  in	  ONS-­‐76	  and	  MRC-­‐5	  cells	  (Figure	  4.17,	  Figure	  4.18).	  As	  time	  0	  samples	  were	  collected	  upon	  inoculation	  and	  preceded	  viral	  entry,	  it	  is	  possible	  that	  the	  values	  obtained	  represent	  contaminating	  DNA	  from	  the	  relatively	  large	  number	  of	  input	  genomes	  present	  at	  this	  time	  point.	  This	  considered,	  the	  conclusions	  stand	  that	  in	  differentiated	  ONS-­‐76	  cells	  wild	  type	  HSV	  replicates	  as	  per	  the	  lytic	  transcriptional	  program	  and	  HSV	  V422	  via	  a	  deviant	  pattern	  of	  gene	  expression.	  Further,	  the	  results	  indicate	  the	  gene	  expression	  profile	  of	  HSV	  V422	  to	  be	  similar	  to	  what	  is	  observed	  during	  HSV	  reactivation.	  
5.3 HSV	  reactivation	  and	  latency	  in	  differentiated	  UW228	  cells	  	   The	  UW228	  medulloblastoma	  cell	  line	  was	  determined	  to	  differentiate	  into	  cells	  that	  retained	  neuronal	  character	  when	  treated	  with	  a	  combination	  of	  NGF	  and	  DBcAMP,	  and	  the	  use	  of	  these	  differentiated	  cells	  as	  a	  model	  of	  HSV	  latency	  was	  assessed.	  Cultures	  of	  differentiated	  UW228	  cells	  were	  found	  to	  stably	  host	  infection	  with	  mutant	  HSV,	  and	  the	  virus	  was	  examined	  for	  its	  ability	  to	  establish	  and	  reactivate	  from	  latency	  in	  this	  system	  using	  a	  traditional	  approach.	  
5.3.1 Establishing	  quiescent	  HSV	  infection	  	   The	  requirements	  for	  establishing	  quiescent	  infection	  in	  differentiated	  UW228	  cells	  were	  determined	  for	  both	  HSV	  KOS	  and	  HSV	  V422.	  Infection	  of	  differentiated	  UW228	  cells	  in	  the	  presence	  of	  viral	  replication	  inhibition	  resulted	  in	  HSV	  KOS	  titers	  gradually	  declining	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from	  input	  levels	  over	  the	  course	  of	  7	  days	  (Figure	  4.10).	  Cultures	  infected	  with	  KOS	  also	  exhibited	  spreading	  CPE	  until	  cell	  death	  was	  complete	  (Figure	  4.11).	  One	  explanation	  of	  these	  results	  is	  that	  small	  amounts	  of	  viral	  replication	  escaped	  restriction	  by	  ACV,	  however	  this	  is	  not	  supported	  by	  the	  transcription	  profile	  of	  the	  wild	  type	  virus.	  As	  cell	  death	  occurred	  in	  the	  absence	  of	  lytic	  transcription	  it	  was	  concluded	  that	  HSV	  KOS	  infection	  of	  differentiated	  UW228	  cells	  was	  not	  compatible	  with	  establishing	  quiescence.	  Differentiated	  UW228	  cells	  were	  also	  infected	  with	  HSV	  V422	  in	  the	  presence	  of	  replication	  inhibition,	  and	  viral	  titers	  were	  observed	  to	  decline	  to	  undetectable	  levels	  by	  day	  4	  (Figure	  4.10).	  Some	  cell	  loss	  was	  observed	  during	  the	  initial	  days	  of	  infection	  (Figure	  4.11),	  however	  the	  mutant	  virus	  had	  an	  overall	  mild	  effect	  on	  culture	  health.	  As	  these	  results	  were	  consistent	  with	  the	  virus	  entering	  quiescence,	  the	  transcriptional	  profile	  of	  HSV	  V422	  under	  these	  infection	  conditions	  was	  characterized.	  An	  initial	  peak	  of	  lytic	  gene	  expression	  was	  observed,	  followed	  by	  a	  drop	  to	  low	  or	  undetectable	  levels	  in	  concert	  with	  the	  disappearance	  of	  infectious	  virus	  from	  culture	  (Figure	  4.12).	  Transcription	  from	  the	  TK	  gene	  (induced	  by	  IE	  gene	  ICP4)	  remained	  detectable	  even	  at	  day	  7	  (Figure	  4.12),	  suggesting	  that	  the	  virus	  persisted	  in	  culture.	  Similar	  low	  levels	  of	  TK	  transcription	  are	  detectable	  in	  latently	  infected	  neurons	  [133]	  although	  the	  etiology	  of	  these	  transcripts	  has	  not	  yet	  been	  resolved.	  The	  LAT	  was	  not	  detected	  above	  background	  levels	  at	  any	  time	  point	  analyzed	  (Figure	  4.12),	  although	  this	  must	  be	  interpreted	  with	  caution	  in	  the	  absence	  of	  a	  positive	  control.	  While	  expression	  of	  the	  LAT	  is	  associated	  with	  quiescence	  [134],	  it	  is	  known	  that	  LAT-­‐positive	  neurons	  do	  not	  represent	  the	  full	  number	  of	  neurons	  harboring	  latent	  HSV	  [135],	  and	  that	  HSV	  latency	  can	  be	  established	  in	  the	  absence	  of	  a	  functional	  LAT	  locus	  [37].	  Collectively	  these	  results	  depict	  HSV	  V422	  infection	  of	  differentiated	  UW228	  cells	  to	  feature	  an	  initial	  period	  of	  lytic	  expression	  and	  detection	  of	  infectious	  virus,	  followed	  by	  a	  second	  phase	  where	  infectious	  virus	  is	  not	  present	  yet	  low	  levels	  of	  TK	  expression	  can	  be	  measured.	  This	  situation	  is	  consistent	  with	  quiescent	  HSV	  infection.	  	  In	  order	  to	  quantify	  and	  characterize	  HSV	  V422	  in	  long-­‐term	  infection	  of	  differentiated	  UW228	  cells,	  the	  amount	  and	  conformation	  of	  persisting	  viral	  DNA	  was	  determined.	  Persistence	  of	  the	  V422	  genome	  in	  infected	  cultures	  was	  examined	  (Figure	  4.13),	  and	  a	  small	  fraction	  of	  the	  input	  virus	  was	  detectable	  for	  the	  duration	  of	  long-­‐term	  infection.	  A	  Gardella	  gel	  was	  also	  performed	  to	  resolve	  if	  persisting	  HSV	  genomes	  adopted	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the	  circular	  conformation	  characteristic	  of	  quiescence	  (Figure	  4.15,	  Figure	  4.16).	  The	  results	  were	  unable	  to	  determine	  the	  configuration	  of	  V422	  in	  infection	  of	  differentiated	  UW228	  cells,	  however,	  as	  the	  amount	  of	  virus	  present	  was	  below	  the	  limit	  of	  detection	  by	  the	  method	  used	  [105].	  These	  results	  confirmed	  that	  HSV	  V422	  genomes	  could	  be	  detected	  in	  cultures	  of	  differentiated	  UW228	  cells	  throughout	  long-­‐term	  infection,	  however	  were	  unable	  to	  indicate	  if	  this	  persisting	  virus	  was	  representative	  of	  quiescent	  infection.	  From	  these	  results	  it	  remains	  unclear	  whether	  HSV	  V422	  infection	  of	  differentiated	  UW228	  cells	  satisfies	  the	  definition	  of	  quiescence.	  Following	  inoculation	  of	  this	  system	  lytic	  gene	  expression	  and	  infectious	  virus	  disappeared,	  while	  viral	  DNA	  and	  low-­‐level	  TK	  transcription	  persisted—a	  situation	  consistent	  with	  quiescence.	  However,	  cell	  density	  was	  also	  observed	  to	  decrease	  following	  infection	  (Figure	  4.11)	  and	  only	  a	  fraction	  of	  input	  viral	  genomes	  were	  retained	  even	  three	  days	  after	  infection	  (Figure	  4.13).	  As	  such,	  these	  results	  could	  also	  describe	  the	  majority	  of	  the	  virus	  being	  lost	  from	  culture	  through	  induction	  of	  cell	  death,	  with	  a	  minority	  of	  residual	  genomes	  persisting.	  As	  the	  Gardella	  gel	  was	  unable	  to	  clarify	  if	  persisting	  genomes	  adopted	  the	  circular	  conformation	  characteristic	  of	  latency,	  it	  remains	  uncertain	  if	  the	  persisting	  virus	  is	  significant.	  Considering	  this	  it	  was	  concluded	  that	  either	  quiescent	  infection	  of	  differentiated	  UW228	  cells	  by	  HSV	  V422	  was	  established	  at	  a	  low	  frequency,	  or	  that	  this	  system	  was	  incompatible	  for	  use	  as	  a	  model	  of	  HSV	  latency.	  The	  determination	  between	  these	  conclusions	  was	  made	  based	  on	  the	  capacity	  of	  the	  virus	  to	  be	  reactivated.	  
5.3.2 Reactivation	  	   To	  assess	  if	  differentiated	  UW228	  cells	  could	  model	  reactivation	  it	  was	  determined	  if	  HSV	  V422	  genomes	  present	  in	  long-­‐term	  infection	  could	  be	  induced	  to	  replicate	  when	  exposed	  to	  classical	  reactivation	  stresses.	  Long-­‐term	  infected	  cultures	  were	  exposed	  to	  forskolin,	  TSA,	  heat	  shock,	  superinfected	  with	  UV-­‐inactivated	  HSV,	  or	  transduced	  with	  cellular	  Luman,	  and	  monitored	  for	  changes	  in	  cell	  morphology	  and	  number	  of	  viral	  genome	  copies	  (Figure	  4.20,	  Figure	  4.21,	  Figure	  4.22).	  Amplification	  of	  HSV	  DNA	  was	  seen	  after	  treatment	  with	  heat	  shock,	  UV-­‐inactivated	  HSV,	  and	  after	  removal	  of	  differentiating	  agents,	  with	  other	  stress	  treatments	  proving	  toxic	  to	  cultures	  independently	  from	  the	  virus.	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An	  increase	  in	  the	  number	  of	  HSV	  genome	  copies	  was	  detected	  after	  treatment	  with	  heat	  shock	  and	  after	  removal	  of	  differentiating	  agents	  (Figure	  4.21),	  with	  twofold	  more	  viral	  DNA	  copies	  found	  in	  cultures	  exposed	  to	  heat	  stress.	  The	  greater	  viral	  DNA	  amplification	  observed	  following	  heat	  shock	  is	  somewhat	  surprising	  in	  light	  of	  indications	  that	  the	  VP16	  activation	  domain	  is	  necessary	  for	  successful	  stress-­‐induced	  reactivation	  [65,	  84,	  88].	  As	  results	  have	  not	  been	  reproduced	  sufficiently	  however	  it	  is	  not	  currently	  possible	  to	  determine	  if	  the	  difference	  between	  treatments	  is	  significant.	  Additionally,	  it	  remains	  to	  be	  determined	  if	  viral	  genome	  amplification	  is	  consistently	  observed.	  Spontaneous	  reactivation	  may	  be	  responsible	  for	  the	  increase	  in	  viral	  DNA,	  as	  these	  events	  have	  been	  observed	  with	  the	  V422	  mutant	  in	  other	  systems	  [84].	  Alternatively,	  the	  addition	  of	  HMBA	  [136]	  or	  withdrawal	  of	  NGF	  from	  culture	  media	  [46]	  during	  co-­‐cultivation	  may	  have	  facilitated	  viral	  replication,	  although	  it	  has	  not	  yet	  been	  resolved	  if	  UW228	  cells	  possess	  a	  functional	  NGF	  signaling	  pathway.	  These	  results	  confirm	  that	  the	  small	  number	  of	  HSV	  V422	  genomes	  persisting	  in	  long-­‐term	  infection	  of	  differentiated	  UW228	  cells	  retain	  the	  ability	  to	  re-­‐enter	  the	  replicative	  cycle.	  Further,	  HSV	  V422	  can	  be	  induced	  to	  re-­‐enter	  the	  productive	  cycle	  by	  exposure	  to	  heat	  shock	  and	  by	  removal	  of	  differentiating	  agents	  from	  culture	  media.	  While	  superinfection	  with	  UV-­‐inactivated	  HSV	  demonstrated	  the	  largest	  increase	  in	  viral	  DNA	  the	  irradiated	  stock	  displayed	  residual	  replicative	  capacity	  (Figure	  4.22),	  obscuring	  the	  results	  of	  providing	  wild	  type	  VP16	  to	  the	  quiescent	  V422	  virus.	  	   The	  reactivation	  stresses	  which	  did	  not	  result	  in	  an	  increase	  in	  viral	  	  DNA	  proved	  to	  be	  incompatible	  for	  use	  in	  this	  system.	  Both	  TSA	  and	  Luman	  expression	  caused	  rapid	  and	  complete	  cell	  death	  (Figure	  4.20).	  As	  TSA	  has	  a	  well-­‐documented	  relationship	  with	  anti-­‐cancer	  effects	  in	  a	  wide	  variety	  of	  tumour	  cell	  lines,	  the	  cell	  death	  observed	  in	  this	  treatment	  group	  is	  unsurprising.	  Based	  on	  the	  functional	  homology	  between	  Luman	  and	  HSV	  VP16	  [122],	  it	  was	  hypothesized	  that	  the	  cellular	  protein	  may	  be	  able	  to	  activate	  the	  quiescent	  virus	  in	  lieu	  of	  wild	  type	  VP16.	  No	  HSV	  DNA	  amplification	  was	  observed	  (Table	  4.3),	  and	  absence	  of	  the	  small	  elevation	  in	  genome	  copies	  detected	  after	  Ad.LacZ	  treatment	  may	  be	  explained	  by	  the	  rapid	  induction	  of	  cell	  death.	  Finally,	  treatment	  with	  forskolin	  did	  not	  result	  in	  the	  emergence	  of	  infectious	  virus	  from	  differentiated	  UW228	  cultures.	  This	  result	  may	  be	  attributable	  to	  the	  V422	  mutation,	  as	  the	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VP16	  activation	  domain	  has	  been	  shown	  to	  be	  required	  for	  forskolin-­‐mediated	  reactivation	  in	  the	  PC-­‐12	  system	  [88].	  Alternatively	  as	  both	  forskolin	  and	  DBcAMP	  induce	  cAMP-­‐dependent	  signaling,	  it	  is	  possible	  that	  the	  lack	  of	  an	  observed	  effect	  may	  be	  due	  to	  the	  competing	  function	  of	  these	  two	  chemicals,	  although	  the	  extent	  of	  the	  molecular	  response	  of	  the	  virus	  following	  treatment	  was	  not	  tested.	  	   These	  observations	  have	  demonstrated	  that	  HSV	  V422	  enters	  into	  low	  frequency	  quiescence	  upon	  infection	  of	  differentiated	  UW228	  cells,	  and	  that	  the	  quiescent	  virus	  can	  be	  induced	  to	  re-­‐enter	  the	  replicative	  cycle.	  From	  this	  it	  can	  be	  concluded	  that	  differentiated	  UW228	  cells	  are	  therefore	  able	  to	  model	  the	  HSV	  latency-­‐reactivation	  cycle.	  
5.4 Use	  of	  differentiated	  medulloblastoma	  cells	  in	  modeling	  the	  latency-­‐reactivation	  cycle	  The	  purpose	  of	  this	  project	  was	  to	  determine	  if	  differentiated	  medulloblastoma	  cells	  could	  provide	  a	  cellular	  environment	  suitable	  for	  investigation	  of	  the	  HSV	  latency-­‐reactivation	  cycle.	  Two	  medulloblastoma	  cell	  lines,	  ONS-­‐76	  and	  UW228,	  were	  differentiated	  and	  assessed	  for	  their	  ability	  to	  host	  HSV	  latency	  and	  reactivation.	  Differentiated	  ONS-­‐76	  cells	  show	  promise	  as	  a	  model	  of	  HSV	  reactivation,	  while	  differentiated	  UW228	  cells	  are	  able	  to	  model	  entry	  into	  and	  exit	  from	  quiescent	  HSV	  infection.	  Neither	  model	  provides	  the	  ideal	  marriage	  of	  human	  and	  neuronal	  factors	  sought	  by	  HSV	  latency	  research,	  and	  both	  systems	  have	  limitations;	  the	  differentiated	  cells	  retain	  characteristics	  of	  both	  neurons	  and	  glia,	  and	  both	  cell	  lines	  require	  infection	  with	  a	  viral	  mutant.	  Additionally,	  the	  frequency	  with	  which	  quiescence	  was	  established	  in	  the	  UW228	  cell	  line	  was	  not	  only	  low,	  but	  also	  highly	  variable	  (Figure	  4.13,	  Figure	  4.21).	  Despite	  these	  shortcomings,	  differentiated	  medulloblastoma	  cells	  provide	  a	  tool	  for	  study	  of	  the	  HSV	  latency-­‐reactivation	  cycle	  that	  has	  not	  as	  of	  yet	  been	  described.	  Medulloblastomas	  are	  distinct	  from	  other	  differentiated	  cell	  models	  in	  that	  they	  originate	  from	  the	  human	  CNS,	  and	  this	  provides	  a	  means	  of	  observing	  HSV	  biology	  from	  a	  different	  cellular	  perspective.	  Lastly,	  this	  body	  of	  work	  can	  be	  used	  to	  inform	  development	  of	  future	  cell	  culture	  models	  based	  on	  human	  neural	  tumour	  cell	  lines.	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